CN106010583B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly Download PDFInfo
- Publication number
- CN106010583B CN106010583B CN201610148390.6A CN201610148390A CN106010583B CN 106010583 B CN106010583 B CN 106010583B CN 201610148390 A CN201610148390 A CN 201610148390A CN 106010583 B CN106010583 B CN 106010583B
- Authority
- CN
- China
- Prior art keywords
- liquid crystal
- formula
- crystal alignment
- tetracarboxylic dianhydride
- moles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/542—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Nonlinear Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
技术领域technical field
本发明是有关于一种液晶配向剂、液晶配向膜及液晶显示组件,特别是关于一种可形成紫外线可靠性佳的液晶配向膜的液晶配向剂、由上述液晶配向剂形成的液晶配向膜以及具有上述液晶配向膜的液晶显示组件。The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display component, in particular to a liquid crystal alignment agent capable of forming a liquid crystal alignment film with good ultraviolet reliability, a liquid crystal alignment film formed by the liquid crystal alignment agent and A liquid crystal display component having the above-mentioned liquid crystal alignment film.
背景技术Background technique
近年来,由于消费者对液晶显示器的广视角特性的要求逐年提升,使得广视角液晶显示组件的电性特性或显示特性的要求变得比以往更为严苛。在广视角液晶显示组件中,以垂直配向型(Vertical Alignment)液晶显示组件最常被研究。因此,为了具有较佳的电性特性及显示特性,液晶配向膜便成为提升垂直配向型液晶显示组件的特性的重要研究对象之一,尤其是大尺寸的液晶电视开始广泛实用化后,相较于主要以显示文字或静止画面为主的显示器,更需要能维持长期使用的信赖性。In recent years, due to the increasing demands of consumers on the wide viewing angle characteristics of liquid crystal displays year by year, the requirements on the electrical characteristics or display characteristics of wide viewing angle liquid crystal display components have become more stringent than before. Among the wide viewing angle liquid crystal display components, vertical alignment liquid crystal display components are most commonly studied. Therefore, in order to have better electrical properties and display properties, liquid crystal alignment films have become one of the important research objects to improve the properties of vertical alignment liquid crystal display components, especially after large-scale liquid crystal TVs are widely used. For displays that mainly display text or still images, it is even more necessary to maintain reliability for long-term use.
日本特开平第9-176651号揭示一种具有高预倾角的液晶配向膜。所述液晶配向膜中同时使用含甾骨架的四羧酸二酐化合物及含甾骨架的二胺化合物,可使液晶配向膜在信赖性试验后仍维持高预倾角。然而,所述液晶配向膜却有紫外线可靠性不佳的问题。具体而言,液晶配向膜经紫外线照射一段时间后,会产生液晶显示器的电压保持率大幅下降的情形,进而造成液晶显示器发生对比度下降等问题。Japanese Patent Application Laid-Open No. 9-176651 discloses a liquid crystal alignment film with a high pretilt angle. The tetracarboxylic dianhydride compound containing a steroid skeleton and the diamine compound containing a steroid skeleton are used in the liquid crystal alignment film at the same time, so that the liquid crystal alignment film can still maintain a high pretilt angle after the reliability test. However, the liquid crystal alignment film has the problem of poor UV reliability. Specifically, after the liquid crystal alignment film is irradiated with ultraviolet rays for a period of time, the voltage retention rate of the liquid crystal display will drop significantly, which in turn will cause problems such as a decrease in the contrast of the liquid crystal display.
因此,如何能提供一种可形成紫外线可靠性佳的液晶配向膜的液晶配向剂,使其所形成的液晶配向膜应用于液晶显示组件时,在紫外线的长期照射下仍得以维持高电压保持率,实为目前本领域技术人员亟欲解决的问题。Therefore, how to provide a liquid crystal alignment agent capable of forming a liquid crystal alignment film with good ultraviolet reliability, so that when the liquid crystal alignment film formed is applied to a liquid crystal display module, it can still maintain a high voltage retention rate under long-term ultraviolet irradiation , is actually a problem that those skilled in the art want to solve urgently.
发明内容Contents of the invention
有鉴于此,本发明提供一种液晶配向剂、液晶配向膜以及液晶显示组件,以提高液晶配向膜的紫外线可靠性。In view of this, the present invention provides a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display component, so as to improve the ultraviolet reliability of the liquid crystal alignment film.
本发明提供一种液晶配向剂,其包括聚合物(A)以及溶剂(B)。聚合物(A)是由混合物反应而获得,其中混合物包括四羧酸二酐组分(a)及二胺组分(b)。四羧酸二酐组分(a)包括由式(1)表示的四羧酸二酐化合物(a-1)。二胺组分(b)包括由式(2)表示的二胺化合物(b-1)。The present invention provides a liquid crystal alignment agent, which includes a polymer (A) and a solvent (B). The polymer (A) is obtained by reacting a mixture including a tetracarboxylic dianhydride component (a) and a diamine component (b). The tetracarboxylic dianhydride component (a) includes a tetracarboxylic dianhydride compound (a-1) represented by formula (1). The diamine component (b) includes a diamine compound (b-1) represented by formula (2).
具体而言,由式(1)表示的四羧酸二酐化合物(a-1)如下所示。Specifically, the tetracarboxylic dianhydride compound (a-1) represented by formula (1) is as follows.
式(1)中,P1、P2、P3及P4各自独立表示单键或亚甲基;j表示1至3的整数。In formula (1), P 1 , P 2 , P 3 and P 4 each independently represent a single bond or a methylene group; j represents an integer of 1 to 3.
另外,由式(2)表示的二胺化合物(b-1)如下所示。In addition, the diamine compound (b-1) represented by formula (2) is as follows.
式(2)中,Y1表示碳数为1至12的亚烷基;Y2表示具有甾骨架的基或由式(2-1)表示的基,其中,由式(2-1)表示的基如下所示。In formula (2), Y 1 represents an alkylene group having a carbon number of 1 to 12; Y 2 represents a group having a steroid skeleton or a group represented by formula (2-1), wherein, represented by formula (2-1) The basis for is as follows.
式(2-1)中,R1各自独立表示氟原子或甲基;R2表示氢原子、氟原子、碳数为1至12的烷基、碳数为1至12的氟烷基、碳数为1至12的烷氧基、-OCH2F、-OCHF2或-OCF3;Z1、Z2及Z3各自独立表示单键、碳数为1至3的亚烷基、-O-、 Z4各自独立表示Ra及Rb各自独立表示氟原子或甲基,h及i各自独立表示0、1或2;a表示0、1或2;b、c及d各自独立表示0至4的整数;e、f及g各自独立表示0至3的整数,且e+f+g≧1。In formula (2-1), R 1 each independently represents a fluorine atom or a methyl group; R 2 represents a hydrogen atom, a fluorine atom, an alkyl group with 1 to 12 carbons, a fluoroalkyl group with 1 to 12 carbons, a carbon Alkoxy group with a number of 1 to 12, -OCH 2 F, -OCHF 2 or -OCF 3 ; Z 1 , Z 2 and Z 3 each independently represent a single bond, an alkylene group with a carbon number of 1 to 3, -O -, Z 4 are independently indicated R a and R b each independently represent a fluorine atom or a methyl group, h and i each independently represent 0, 1 or 2; a represents 0, 1 or 2; b, c and d each independently represent an integer from 0 to 4; e, f and g each independently represent an integer of 0 to 3, and e+f+g≧1.
在本发明的一实施例中,基于上述四羧酸二酐组分(a)的总摩尔数为100,上述四羧酸二酐化合物(a-1)的使用量为5摩尔至50摩尔。In one embodiment of the present invention, based on the total number of moles of the tetracarboxylic dianhydride component (a) being 100, the amount of the tetracarboxylic dianhydride compound (a-1) used is 5 to 50 moles.
在本发明的一实施例中,基于所上述二胺组分(b)的总摩尔数为100摩尔,上述二胺化合物(b-1)的使用量为3摩尔至20摩尔。In one embodiment of the present invention, based on the total moles of the diamine component (b) being 100 moles, the amount of the diamine compound (b-1) used is 3 to 20 moles.
在本发明的一实施例中,上述的聚合物(A)的酰亚胺化率为30%至90%。In an embodiment of the present invention, the imidization rate of the above-mentioned polymer (A) is 30% to 90%.
本发明另提供一种液晶配向膜,其是由上述的液晶配向剂而形成。The present invention further provides a liquid crystal alignment film formed from the above-mentioned liquid crystal alignment agent.
本发明还提供一种液晶显示组件,其包括上述的液晶配向膜。The present invention also provides a liquid crystal display component, which includes the above-mentioned liquid crystal alignment film.
基于上述,本发明的液晶配向剂、液晶配向膜以及液晶显示组件,其液晶配向剂所形成液晶配向膜的紫外线可靠性佳,而适用于液晶显示组件。Based on the above, the liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display assembly of the present invention have good ultraviolet reliability of the liquid crystal alignment film formed by the liquid crystal alignment agent, and are suitable for liquid crystal display assemblies.
为让本发明的上述特征和优点能更明显易懂,下文特举实施例,并配合附图作详细说明如下。In order to make the above-mentioned features and advantages of the present invention more comprehensible, the following specific embodiments are described in detail with reference to the accompanying drawings.
附图说明Description of drawings
图1是本发明一实施例的液晶显示组件的侧视图。FIG. 1 is a side view of a liquid crystal display module according to an embodiment of the present invention.
附图标记说明:Explanation of reference signs:
100:液晶显示组件;100: liquid crystal display component;
110:第一单元;110: first unit;
112:第一基板;112: the first substrate;
114:第一导电膜;114: the first conductive film;
116:第一液晶配向膜;116: a first liquid crystal alignment film;
120:第二单元;120: second unit;
122:第二基板;122: a second substrate;
124:第二导电膜;124: the second conductive film;
126:第二液晶配向膜;126: a second liquid crystal alignment film;
130:液晶单元。130: a liquid crystal unit.
具体实施方式Detailed ways
<液晶配向剂><Liquid crystal alignment agent>
本发明提供一种液晶配向剂,其包括聚合物(A)以及溶剂(B)。此外,若需要,液晶配向剂可还包括添加剂(C)。The present invention provides a liquid crystal alignment agent, which includes a polymer (A) and a solvent (B). In addition, the liquid crystal alignment agent may further include an additive (C) if necessary.
以下将详细说明用于本发明的液晶配向剂的各个成分。Each component of the liquid crystal alignment agent used in the present invention will be described in detail below.
在此说明的是,以下是以(甲基)丙烯酸表示丙烯酸和/或甲基丙烯酸,并以(甲基)丙烯酸酯表示丙烯酸酯和/或甲基丙烯酸酯;同样地,以(甲基)丙烯酰基表示丙烯酰基和/或甲基丙烯酰基。It is explained here that (meth)acrylic acid is used to represent acrylic acid and/or methacrylic acid, and (meth)acrylate is used to represent acrylate and/or methacrylate; similarly, (meth) Acryloyl means acryloyl and/or methacryloyl.
聚合物(A)Polymer (A)
聚合物(A)是由混合物反应而获得,混合物包括四羧酸二酐组分(a)及二胺组分(b)。The polymer (A) is obtained by reacting a mixture including a tetracarboxylic dianhydride component (a) and a diamine component (b).
详细而言,聚合物(A)包括聚酰胺酸、聚酰亚胺、聚酰胺酸-聚酰亚胺嵌段共聚合物或这些聚合物的组合。其中,聚酰亚胺系嵌段共聚合物包括聚酰胺酸嵌段共聚合物、聚酰亚胺嵌段共聚合物、聚酰胺酸-聚酰亚胺嵌段共聚合物或上述聚合物的组合。聚酰胺酸聚合物、聚酰亚胺聚合物及聚酰胺酸-聚酰亚胺嵌段共聚合物均可由四羧酸二酐组分(a)及二胺组分(b)的混合物反应所制得。Specifically, the polymer (A) includes polyamic acid, polyimide, polyamic acid-polyimide block copolymer, or a combination of these polymers. Wherein, the polyimide series block copolymer comprises polyamic acid block copolymer, polyimide block copolymer, polyamic acid-polyimide block copolymer or the polyamic acid block copolymer combination. Polyamic acid polymers, polyimide polymers and polyamic acid-polyimide block copolymers can all be formed by the mixture reaction of tetracarboxylic dianhydride component (a) and diamine component (b). be made of.
四羧酸二酐组分(a)Tetracarboxylic dianhydride component (a)
四羧酸二酐组分(a)包括四羧酸二酐化合物(a-1)以及四羧酸二酐化合物(a-2)。The tetracarboxylic dianhydride component (a) includes a tetracarboxylic dianhydride compound (a-1) and a tetracarboxylic dianhydride compound (a-2).
四羧酸二酐化合物(a-1)Tetracarboxylic dianhydride compound (a-1)
四羧酸二酐化合物(a-1)为由式(1)所表示的化合物。Tetracarboxylic dianhydride compound (a-1) is a compound represented by formula (1).
式(1)中,P1、P2、P3及P4各自独立表示单键或亚甲基;j表示1至3的整数。在式(1)中,j较佳为表示1至2,更佳为表示1。In formula (1), P 1 , P 2 , P 3 and P 4 each independently represent a single bond or a methylene group; j represents an integer of 1 to 3. In formula (1), j preferably represents 1 to 2, and more preferably represents 1.
由式(1)表示的四羧酸二酐化合物(a-1)中,j表示1的具体例包括但不限于双环[3.3.0]辛烷-2,4,6,8-四羧酸二酐(由式(1-1)表示的化合物)、双环[4.3.0]壬烷-2,4,7,9-四羧酸二酐(由式(1-2)表示的化合物)、双环[4.4.0]癸烷-2,4,8,10-四羧酸二酐(由式(1-3)表示的化合物)、双环[4.4.0]癸烷-2,4,7,9-四羧酸二酐(由式(1-4)表示的化合物),或其组合。In the tetracarboxylic dianhydride compound (a-1) represented by formula (1), specific examples where j represents 1 include but are not limited to bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic acid Dianhydride (compound represented by formula (1-1)), bicyclo[4.3.0]nonane-2,4,7,9-tetracarboxylic dianhydride (compound represented by formula (1-2)), Bicyclo[4.4.0]decane-2,4,8,10-tetracarboxylic dianhydride (compound represented by formula (1-3)), bicyclo[4.4.0]decane-2,4,7, 9-tetracarboxylic dianhydride (compound represented by formula (1-4)), or a combination thereof.
另外,由式(1)表示的四羧酸二酐化合物(a-1)中,j表示2的具体例包括但不限于三环[6.3.0.02,6]十一烷-3,5,9,11-四羧酸二酐(由式(1-5)表示的化合物)。In addition, in the tetracarboxylic dianhydride compound (a-1) represented by formula (1), specific examples where j represents 2 include, but are not limited to, tricyclo[6.3.0.0 2,6 ]undecane-3,5, 9,11-tetracarboxylic dianhydride (compound represented by formula (1-5)).
由式(1)表示的四羧酸二酐化合物(a-1)的具体例较佳为包括双环[3.3.0]辛烷-2,4,6,8-四羧酸二酐(由式(1-1)表示的化合物)、双环[4.3.0]壬烷-2,4,7,9-四羧酸二酐(由式(1-2)表示的化合物)、三环[6.3.0.02,6]十一烷-3,5,9,11-四羧酸二酐(由式(1-5)表示的化合物),或其组合。Specific examples of the tetracarboxylic dianhydride compound (a-1) represented by the formula (1) preferably include bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride (formulated by the formula (1-1) represented), bicyclo[4.3.0]nonane-2,4,7,9-tetracarboxylic dianhydride (compound represented by formula (1-2)), tricyclo[6.3. 0.0 2,6 ] Undecane-3,5,9,11-tetracarboxylic dianhydride (compound represented by formula (1-5)), or a combination thereof.
四羧酸二酐化合物(a-1)可具有异构体结构,并且可使用一种类型的异构体或是使用异构体的混合物。以双环[3.3.0]辛烷-2,4,6,8-四羧酸二酐为例,其可具有下列式(1-1-a)、式(1-1-b)或式(1-1-c)所示的结构。The tetracarboxylic dianhydride compound (a-1) may have an isomer structure, and either one type of isomer or a mixture of isomers may be used. Taking bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride as an example, it can have the following formula (1-1-a), formula (1-1-b) or formula ( The structure shown in 1-1-c).
双环[3.3.0]辛烷-2,4,6,8-四羧酸二酐是例如可通过以下方法来合成。首先,将2,5-降冰片二烯(2,5-norbornadiene)与二环戊二烯(dicyclopentadiene)在高压釜中,在190℃的温度下反应20小时,以形成四环[6.2.1.13,6.02,7]十二-4,9-二烯。接着,将所得化合物于甲醇中,在-30℃的环境下进行臭氧化反应(Ozonolysis)后,并于甲酸和乙酸的混合溶剂中使用过氧化氢进行氧化分解,以形成双环[3.3.0]辛烷-2,4,6,8-四羧酸(Bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylicacid,简称BOTA)。将BOTA加入乙酸酐,并经过加热处理后可得到双环[3.3.0]辛烷-2,4,6,8-四羧酸二酐。另外,BOTA也可通过将四环[6.2.1.13,6.02,7]十二-4,9-二烯通过过锰酸钾氧化处理而形成。Bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride can be synthesized, for example, by the following method. First, 2,5-norbornadiene (2,5-norbornadiene) and dicyclopentadiene (dicyclopentadiene) were reacted in an autoclave at a temperature of 190°C for 20 hours to form tetracyclic [6.2.1.1 3,6 .0 2,7 ]Dodeca-4,9-diene. Next, the resulting compound was subjected to an ozonolysis reaction (Ozonolysis) in methanol at -30°C, and then oxidatively decomposed using hydrogen peroxide in a mixed solvent of formic acid and acetic acid to form a bicyclic [3.3.0] Octane-2,4,6,8-tetracarboxylic acid (Bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic acid, BOTA for short). Add BOTA to acetic anhydride and heat treatment to obtain bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride. In addition, BOTA can also be formed by oxidizing tetracyclo[6.2.1.1 3,6 .0 2,7 ]dodeca-4,9-diene with potassium permanganate.
基于四羧酸二酐组分(a)的总使用量为100摩尔,四羧酸二酐化合物(a-1)的使用量可为5摩尔至50摩尔,较佳为8摩尔至45摩尔,更佳为10摩尔至40摩尔。当液晶配向剂不使用四羧酸二酐化合物(a-1)时,则液晶配向膜有紫外线可靠性不佳的问题。Based on the total amount of tetracarboxylic dianhydride component (a) used as 100 moles, the amount of tetracarboxylic dianhydride compound (a-1) used can be from 5 moles to 50 moles, preferably from 8 moles to 45 moles, More preferably, it is 10 mol to 40 mol. When the liquid crystal alignment agent does not use the tetracarboxylic dianhydride compound (a-1), the liquid crystal alignment film has the problem of poor UV reliability.
四羧酸二酐化合物(a-2)Tetracarboxylic dianhydride compound (a-2)
四羧酸二酐化合物(a-2)包括脂肪族四羧酸二酐化合物、脂环族四羧酸二酐化合物、芳香族四羧酸二酐化合物、由式(I-1)至式(I-6)表示的四羧酸二酐化合物中的至少一种,或上述化合物的组合。Tetracarboxylic dianhydride compound (a-2) comprises aliphatic tetracarboxylic dianhydride compound, alicyclic tetracarboxylic dianhydride compound, aromatic tetracarboxylic dianhydride compound, by formula (I-1) to formula ( At least one of the tetracarboxylic dianhydride compounds represented by I-6), or a combination of the above-mentioned compounds.
以下列举脂肪族四羧酸二酐化合物、脂环族四羧酸二酐化合物、芳香族四羧酸二酐化合物的具体例,但本发明并不限于这些具体例。Although the specific example of an aliphatic tetracarboxylic dianhydride compound, an alicyclic tetracarboxylic dianhydride compound, and an aromatic tetracarboxylic dianhydride compound is mentioned below, this invention is not limited to these specific examples.
脂肪族四羧酸二酐化合物的具体例可包括但不限于乙烷四羧酸二酐(ethanetetracarboxylic dianhydride)、丁烷四羧酸二酐(butane tetracarboxylicdianhydride)或上述化合物的组合。Specific examples of the aliphatic tetracarboxylic dianhydride compound may include, but are not limited to, ethanetetracarboxylic dianhydride, butane tetracarboxylic dianhydride, or combinations of the above compounds.
脂环族四羧酸二酐化合物的具体例可包括但不限于1,2,3,4-环丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-环丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-环丁烷四羧酸二酐、1,3-二氯-1,2,3,4-环丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-环丁烷四羧酸二酐、1,2,3,4-环戊烷四羧酸二酐、1,2,4,5-环己烷四羧酸二酐、3,3’,4,4’-二环己基四羧酸二酐、顺式-3,7-二丁基环庚基-1,5-二烯-1,2,5,6-四羧酸二酐或2,3,5-三羧基环戊基醋酸二酐或上述化合物的组合。Specific examples of alicyclic tetracarboxylic dianhydride compounds may include, but are not limited to, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4- Cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutane Butane tetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic Acid dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutylcycloheptane 1,5-diene-1,2,5,6-tetracarboxylic dianhydride or 2,3,5-tricarboxycyclopentylacetic dianhydride or a combination of the above compounds.
芳香族四羧酸二酐化合物的具体例可包括但不限于3,4-二羧基-1,2,3,4-四氢萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-联苯砜四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’-4,4’-二苯基乙烷四羧酸二酐、3,3’,4,4’-二甲基二苯基硅烷四羧酸二酐、3,3’,4,4’-四苯基硅烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-双(3,4-二羧基苯氧基)二苯硫醚二酐、4,4’-双(3,4-二羧基苯氧基)二苯砜二酐、4,4’-双(3,4-二羧基苯氧基)二苯丙烷二酐(4,4’-bis(3,4-dicarboxy phenoxy)diphenylpropane dianhydride)、3,3’,4,4’-全氟异亚丙基二苯二酸二酐、3,3’,4,4’-二苯基四羧酸二酐、双(苯二酸)苯膦氧化物二酐、对-亚苯基-双(三苯基苯二酸)二酐、间-亚苯基-双(三苯基苯二酸)二酐、双(三苯基苯二酸)-4,4’-二苯基醚二酐、双(三苯基苯二酸)-4,4’-二苯基甲烷二酐、乙二醇-双(脱水偏苯三酸酯)、丙二醇-双(脱水偏苯三酸酯)、1,4-丁二醇-双(脱水偏苯三酸酯)、1,6-己二醇-双(脱水偏苯三酸酯)、1,8-辛二醇-双(脱水偏苯三酸酯)、2,2-双(4-羟苯基)丙烷-双(脱水偏苯三酸酯)、2,3,4,5-四氢呋喃四羧酸二酐、1,3,3a,4,5,9b-六氢-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮{(1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)naphtho[1,2-c]furan-1,3-dione)}、1,3,3a,4,5,9b-六氢-5-甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-5-乙基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-7-甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-7-乙基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-8-甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-8-乙基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-5,8-二甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二侧氧基四氢呋喃基)-3-甲基-3-环己烯-1,2-二羧酸二酐等芳香族四羧酸二酐化合物或上述化合物的组合。Specific examples of aromatic tetracarboxylic dianhydride compounds may include, but are not limited to, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenylsulfone tetracarboxylic dianhydride, 1,4,5,8-naphthalene tetracarboxylic Acid dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 3,3'-4,4'-diphenylethanetetracarboxylic dianhydride, 3,3',4,4'- Dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1,2,3,4-furan tetracarboxylic dianhydride, 4, 4'-bis(3,4-dicarboxyphenoxy)diphenylsulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylsulfone dianhydride, 4,4'- Bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride (4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride), 3,3',4,4'-perfluoroiso Propyl diphthalic dianhydride, 3,3',4,4'-diphenyltetracarboxylic dianhydride, bis(phthalic acid)phenylphosphine oxide dianhydride, p-phenylene-bis(tri Phenylphthalic acid) dianhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylether dianhydride, bis (Triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-bis(anhydrotrimellitate), propylene glycol-bis(anhydrotrimellitate), 1,4 -Butanediol-bis(anhydrotrimellitate), 1,6-Hexanediol-bis(anhydrotrimellitate), 1,8-octanediol-bis(anhydrotrimellitate) , 2,2-bis(4-hydroxyphenyl)propane-bis(dehydrated trimellitate), 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3a,4,5, 9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione {(1,3, 3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)naphtho[1,2-c]furan-1,3-dione)}, 1,3,3a,4 ,5,9b-Hexahydro-5-methyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3- Diketone, 1,3,3a,4,5,9b-hexahydro-5-ethyl-5-(tetrahydro-2,5-dipentoxy-3-furyl)-naphtho[1,2 -c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-methyl-5-(tetrahydro-2,5-dioxo-3- Furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-ethyl-5-(tetrahydro-2 ,5-Dioxo-3-furyl)-naphtho[ 1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo -3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-(tetra Hydrogen-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro -5,8-Dimethyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 5 -Aromatic tetracarboxylic dianhydride compounds such as (2,5-dipentoxytetrahydrofuryl)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride or combinations of the above-mentioned compounds.
由式(I-1)至式(I-6)表示的四羧酸二酐化合物如下所示。The tetracarboxylic dianhydride compounds represented by formula (I-1) to formula (I-6) are shown below.
式(I-5)中,A1表示含有芳香环的二价基团;r表示1至2的整数;A2及A3可为相同或不同,且可各自独立表示氢原子或烷基。由式(I-5)表示的四羧酸二酐化合物的具体例包括由式(I-5-1)至式(I-5-3)表示的化合物中的至少一种。In formula (I-5), A 1 represents a divalent group containing an aromatic ring; r represents an integer from 1 to 2; A 2 and A 3 may be the same or different, and may each independently represent a hydrogen atom or an alkyl group. Specific examples of the tetracarboxylic dianhydride compound represented by formula (I-5) include at least one of the compounds represented by formula (I-5-1) to formula (I-5-3).
式(I-6)中,A4表示含有芳香环的二价基团;A5及A6可为相同或不同,且各自独立表示氢原子或烷基。由式(I-6)表示的四羧酸二酐化合物较佳为由式(I-6-1)表示的化合物。In formula (I-6), A 4 represents a divalent group containing an aromatic ring; A 5 and A 6 may be the same or different, and each independently represents a hydrogen atom or an alkyl group. The tetracarboxylic dianhydride compound represented by formula (I-6) is preferably a compound represented by formula (I-6-1).
四羧酸二酐化合物(a-2)可以单独使用或者组合多种来使用。The tetracarboxylic dianhydride compound (a-2) can be used individually or in combination of multiple types.
四羧酸二酐化合物(a-2)的具体例较佳为包括1,2,3,4-环丁烷四羧酸二酐(1,2,3,4-cyclobutane tetracarboxylic dianhydride)、1,2,3,4-环戊烷四羧酸二酐、2,3,5-三羧基环戊基醋酸二酐(2,3,5-tricarboxycyclopentylacetic dianhydride)、1,2,4,5-环己烷四羧酸二酐、3,4-二羧基-1,2,3,4-四氢萘-1-琥珀酸二酐、苯均四羧酸二酐(pyromellitic dianhydride)、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-联苯砜四羧酸二酐、式(I-1)表示的化合物或上述化合物的组合。Specific examples of the tetracarboxylic dianhydride compound (a-2) preferably include 1,2,3,4-cyclobutane tetracarboxylic dianhydride (1,2,3,4-cyclobutane tetracarboxylic dianhydride), 1, 2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride (2,3,5-tricarboxycyclopentylacetic dianhydride), 1,2,4,5-cyclohexyl Alkanetetracarboxylic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3', 4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenyl sulfone tetracarboxylic dianhydride, a compound represented by formula (I-1), or a combination of these compounds.
基于四羧酸二酐组分(a)的总摩尔数为100摩尔,四羧酸二酐化合物(a-2)的使用量可为50摩尔至95摩尔,较佳为55摩尔至92摩尔,且更佳为60摩尔至90摩尔。Based on the total number of moles of the tetracarboxylic dianhydride component (a) being 100 moles, the amount of the tetracarboxylic dianhydride compound (a-2) can be from 50 moles to 95 moles, preferably from 55 moles to 92 moles, And more preferably from 60 mol to 90 mol.
基于二胺组分(b)的总摩尔数为100摩尔,四羧酸二酐组分(a)的使用量范围较佳为20摩尔至200摩尔,更佳为30摩尔至120摩尔。Based on 100 moles of the total moles of the diamine component (b), the tetracarboxylic dianhydride component (a) is preferably used in an amount ranging from 20 moles to 200 moles, more preferably from 30 moles to 120 moles.
二胺组分(b)Diamine component (b)
二胺组分(b)包括二胺化合物(b-1)以及二胺化合物(b-2)。The diamine component (b) includes a diamine compound (b-1) and a diamine compound (b-2).
二胺化合物(b-1)Diamine compound (b-1)
二胺化合物(b-1)为由式(2)表示的化合物。The diamine compound (b-1) is a compound represented by formula (2).
式(2)中,Y1表示碳数为1至12的亚烷基;Y2表示具有甾(胆固醇,steroid)骨架的基或由式(2-1)表示的基。In formula (2), Y 1 represents an alkylene group having a carbon number of 1 to 12; Y 2 represents a group having a steroid (cholesterol, steroid) skeleton or a group represented by formula (2-1).
由式(2-1)表示的基如下所示。The group represented by formula (2-1) is as follows.
式(2-1)中,R1各自独立表示氟原子或甲基;R2表示氢原子、氟原子、碳数为1至12的烷基、碳数为1至12的氟烷基、碳数为1至12的烷氧基、-OCH2F、-OCHF2或-OCF3;Z1、Z2及Z3各自独立表示单键、碳数为1至3的亚烷基、-O-、 Z4各自独立表示 Ra及Rb各自独立表示氟原子或甲基,h及i各自独立表示0、1或2;a表示0、1或2;b、c及d各自独立表示0至4的整数;e、f及g各自独立表示0至3的整数,且e+f+g≧1。In formula (2-1), R 1 each independently represents a fluorine atom or a methyl group; R 2 represents a hydrogen atom, a fluorine atom, an alkyl group with 1 to 12 carbons, a fluoroalkyl group with 1 to 12 carbons, a carbon Alkoxy group with a number of 1 to 12, -OCH 2 F, -OCHF 2 or -OCF 3 ; Z 1 , Z 2 and Z 3 each independently represent a single bond, an alkylene group with a carbon number of 1 to 3, -O -, Z 4 are independently indicated R a and R b each independently represent a fluorine atom or a methyl group, h and i each independently represent 0, 1 or 2; a represents 0, 1 or 2; b, c and d each independently represent an integer from 0 to 4; e, f and g each independently represent an integer of 0 to 3, and e+f+g≧1.
二胺化合物(b-1)的具体例包括由式(2-2)至式(2-19)表示的化合物中的至少一种。Specific examples of the diamine compound (b-1) include at least one of the compounds represented by formula (2-2) to formula (2-19).
二胺化合物(b-1)可利用一般的有机合成方法来制备。举例而言,由式(2-2)至式(2-19)表示的化合物可分别于具有甾骨架的化合物或由式(2-20)表示的化合物上加成马来酸酐后,在碳酸钾的存在下,加入二硝基苯酰氯化合物以进行酯化反应。然后,加入氯化锡等适当的还原剂来进行还原反应,以合成二胺化合物(b-1)。The diamine compound (b-1) can be produced by a general organic synthesis method. For example, the compounds represented by formula (2-2) to formula (2-19) can be added maleic anhydride on the compound having steroid skeleton or by the compound represented by formula (2-20) respectively, In the presence of potassium, a dinitrobenzoyl chloride compound is added for esterification. Then, a suitable reducing agent such as tin chloride is added to perform a reduction reaction to synthesize a diamine compound (b-1).
式(2-20)中,R1、R2、Z1、Z2、Z3、Z4、a、b、c、d、e、f及g的定义分别与式(2-1)中的R1、R2、Z1、Z2、Z3、Z4、a、b、c、d、e、f及g的定义相同,在此不另行赘述。In formula (2-20), the definitions of R 1 , R 2 , Z 1 , Z 2 , Z 3 , Z 4 , a, b, c, d, e, f and g are the same as in formula (2-1) The definitions of R 1 , R 2 , Z 1 , Z 2 , Z 3 , Z 4 , a, b, c, d, e, f and g are the same, and will not be repeated here.
由式(2-20)表示的化合物可利用一般用以合成液晶性化合物所使用的格林纳反应(Grignard reaction)或佛瑞德-克来福特酰化反应(Friedal-Crafts acylationreaction)等方法来合成。The compound represented by formula (2-20) can be synthesized by methods such as Grignard reaction or Friedal-Crafts acylation reaction (Friedal-Crafts acylation reaction), which are generally used to synthesize liquid crystal compounds. .
由式(2)表示的二胺化合物(b-1)较佳为选自由式(2-2)、式(2-7)、式(2-10)、式(2-15)、式(2-17)、式(2-18)表示的二胺化合物所组成的族群中的至少一种。The diamine compound (b-1) represented by formula (2) is preferably selected from formula (2-2), formula (2-7), formula (2-10), formula (2-15), formula ( 2-17), at least one of the group consisting of diamine compounds represented by formula (2-18).
基于二胺组分(b)的使用量为100摩尔,二胺化合物(b-1)的使用量可为3摩尔至20摩尔,较佳为4摩尔至18摩尔,且更佳为5摩尔至15摩尔。当液晶配向剂不使用二胺化合物(b-1)时,则液晶配向膜有紫外线可靠性不佳的问题。Based on the usage amount of diamine component (b) being 100 moles, the usage amount of diamine compound (b-1) can be 3 moles to 20 moles, preferably 4 moles to 18 moles, and more preferably 5 moles to 15 moles. When the liquid crystal alignment agent does not use the diamine compound (b-1), the liquid crystal alignment film has the problem of poor UV reliability.
二胺化合物(b-2)Diamine compound (b-2)
二胺化合物(b-2)包括脂肪族二胺化合物、脂环族二胺化合物、芳香族二胺化合物、具有结构式(II-1)至式(II-30)的二胺化合物、或其组合。Diamine compounds (b-2) include aliphatic diamine compounds, alicyclic diamine compounds, aromatic diamine compounds, diamine compounds with structural formula (II-1) to formula (II-30), or combinations thereof .
脂肪族二胺化合物的具体例包括但不限于1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4’-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-双(3-胺基丙氧基)乙烷,或上述化合物的组合。Specific examples of aliphatic diamine compounds include, but are not limited to, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane , 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diaminodecane , 4,4'-diaminoheptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7 -Diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1, 9-Diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane Alkanes, or combinations of the above compounds.
脂环族二胺化合物的具体例包括但不限于4,4’-二胺基二环己基甲烷、4,4’-二胺基-3,3’-二甲基二环己基胺、1,3-二胺基环己烷、1,4-二胺基环己烷、异佛尔酮二胺、四氢二环戊二烯二胺、三环[6.2.1.02,7]-十一碳烯二甲基二胺、4,4’-亚甲基双(环己基胺),或上述化合物的组合。Specific examples of alicyclic diamine compounds include, but are not limited to, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1, 3-Diaminocyclohexane, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienediamine, tricyclo[6.2.1.0 2,7 ]-undeca Carbenedimethyldiamine, 4,4'-methylenebis(cyclohexylamine), or a combination of the above compounds.
芳香族二胺化合物的具体例包括但不限于4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基乙烷、4,4’-二胺基二苯基砜、4,4’-二胺基苯甲酰苯胺、4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氢茚、6-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氢茚、六氢-4,7-甲桥亚氢茚基二亚甲基二胺、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-双[4-(4-胺基苯氧基)苯基]丙烷、2,2-双[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-双(4-胺基苯基)六氟丙烷、2,2-双[4-(4-胺基苯氧基)苯基]砜、1,4-双(4-胺基苯氧基)苯、1,3-双(4-胺基苯氧基)苯、1,3-双(3-胺基苯氧基)苯、9,9-双(4-胺基苯基)-10-氢蒽、9,10-双(4-胺基苯基)蒽[9,10-bis(4-aminophenyl)anthracene]、2,7-二胺基茀、9,9-双(4-胺基苯基)茀、4,4’-亚甲基-双(2-氯苯胺)、4,4’-(对-亚苯基异亚丙基)双苯胺、4,4’-(间-亚苯基异亚丙基)双苯胺、2,2’-双[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’-双[(4-胺基-2-三氟甲基)苯氧基]-八氟联苯、5-[4-(4-正戊烷基环己基)环己基]苯基-亚甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}、1,1-双[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)环己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane},或上述化合物的组合。Specific examples of aromatic diamine compounds include, but are not limited to, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenyl Sulfone, 4,4'-diaminobenzanilide, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, 6-amino-1-(4'-aminophenyl)-1,3, 3-trimethylhydroindene, hexahydro-4,7-methyleneindenylidene dimethylenediamine, 3,3'-diaminobenzophenone, 3,4'-diaminodi Benzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4- Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl] Sulfone, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 9,10-bis(4-aminophenyl)anthracene [9,10-bis(4-aminophenyl)anthracene], 2,7 -Diamino fluorene, 9,9-bis(4-aminophenyl) fluorene, 4,4'-methylene-bis(2-chloroaniline), 4,4'-(p-phenylene iso Propylene)bisaniline, 4,4'-(m-phenylene isopropylidene)bisaniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy )phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, 5-[4-(4-n-pentyl Cyclohexyl)cyclohexyl]phenyl-methylene-1,3-diaminobenzene {5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}, 1,1-bis [4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4 -ethylphenyl)cyclohexane}, or a combination of the above compounds.
具有结构式(II-1)至式(II-30)的二胺化合物如下所示。Diamine compounds having structural formula (II-1) to formula (II-30) are shown below.
式(II-1)中,B1表示-O-、B2表示具有甾(胆固醇(steroid))骨架的基、三氟甲基、氟基、碳数为2至30的烷基、或衍生自吡啶、嘧啶、三嗪、呱啶或呱嗪等含氮原子环状结构的一价基团。In formula (II-1), B 1 represents -O-, B 2 represents a group having a steroid (steroid) skeleton, a trifluoromethyl group, a fluoro group, an alkyl group with a carbon number of 2 to 30, or a group derived from pyridine, pyrimidine, triazine, piperidine or piperazine, etc. A monovalent group with a ring structure of a nitrogen atom.
由式(II-1)表示的化合物的具体例包括但不限于2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethylformate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diaminobenzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)、由式(II-1-1)至式(II-1-6)表示的化合物中的至少其中一种,或上述化合物的组合。Specific examples of compounds represented by formula (II-1) include, but are not limited to, 2,4-diaminophenyl ethyl formate (2,4-diaminophenyl ethyl formate), 3,5-diaminophenyl formic acid ethyl Esters (3,5-diaminophenyl ethylformate), 2,4-diaminophenyl propyl formate (2,4-diaminophenyl propyl formate), 3,5-diaminophenyl propyl formate (3,5-diaminophenyl propyl formate), 1-dodecyloxy-2,4-diaminobenzene (1-dodecoxy-2,4-diaminobenzene), 1-hexadecyloxy-2,4-diaminobenzene (1 -hexadecoxy-2,4-diaminobenzene), 1-octadecyloxy-2,4-diaminobenzene (1-octadecoxy-2,4-diaminobenzene), from formula (II-1-1) to formula ( At least one of the compounds represented by II-1-6), or a combination of the above compounds.
由式(II-1-1)至式(II-1-6)表示的化合物如下所示。Compounds represented by formula (II-1-1) to formula (II-1-6) are shown below.
式(II-2)中,B1与式(II-1)中的B1相同,B3及B4各自独立表示二价脂肪族环、二价芳香族环或二价杂环基团;B5表示碳数为3至18的烷基、碳数为3至18的烷氧基、碳数为1至5的氟烷基、碳数为1至5的氟烷氧基、氰基或卤素原子。In formula (II-2), B1 is the same as B1 in formula (II-1), and B3 and B4 each independently represent a divalent alicyclic ring, a divalent aromatic ring or a divalent heterocyclic group; B5 represents an alkyl group with a carbon number of 3 to 18, an alkoxy group with a carbon number of 3 to 18, a fluoroalkyl group with a carbon number of 1 to 5, a fluoroalkoxy group with a carbon number of 1 to 5, a cyano group or halogen atom.
由式(II-2)表示的化合物的具体例包括由式(II-2-1)至式(II-2-13)表示的化合物中的至少其中一种。具体而言,由式(II-2-1)至式(II-2-13)表示的化合物如下所示。Specific examples of the compound represented by formula (II-2) include at least one of the compounds represented by formula (II-2-1) to formula (II-2-13). Specifically, compounds represented by formula (II-2-1) to formula (II-2-13) are shown below.
式(II-2-10)至式(II-2-13)中,s表示3至12的整数。In formula (II-2-10) to formula (II-2-13), s represents an integer of 3 to 12.
式(II-3)中,B6各自独立表示氢原子、碳数为1至5的酰基、碳数为1至5的烷基、碳数为1至5的烷氧基或卤素原子,且每个重复单元中的B6可为相同或不同;u表示1至3的整数。In formula (II-3), B6 each independently represents a hydrogen atom, an acyl group with 1 to 5 carbons, an alkyl group with 1 to 5 carbons, an alkoxy group with 1 to 5 carbons, or a halogen atom, and B 6 in each repeating unit may be the same or different; u represents an integer of 1 to 3.
由式(II-3)表示的化合物的具体例包括当u为1时:对-二胺苯、间-二胺苯、邻-二胺苯或2,5-二胺基甲苯等;当u为2时:4,4’-二胺基联苯、2,2’-二甲基-4,4’-二胺基联苯、3,3’-二甲基-4,4’-二胺基联苯、3,3’-二甲氧基-4,4’-二胺基联苯、2,2’-二氯-4,4’-二胺基联苯、3,3’-二氯-4,4’-二胺基联苯、2,2’,5,5’-四氯-4,4’-二胺基联苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基联苯或4,4’-二胺基-2,2’-双(三氟甲基)联苯等;或当u为3时:1,4-双(4’-胺基苯基)苯等。Specific examples of compounds represented by formula (II-3) include when u is 1: p-diaminobenzene, m-diaminobenzene, o-diaminotoluene, or 2,5-diaminotoluene, etc.; when u When it is 2: 4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-di Aminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diaminobiphenyl, 3,3'- Dichloro-4,4'-diaminobiphenyl, 2,2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4' -Diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, etc.; or when u is 3: 1 , 4-bis(4'-aminophenyl)benzene and so on.
由式(II-3)表示的化合物的具体例较佳为包括对-二胺苯、2,5-二胺基甲苯、4,4’-二胺基联苯、3,3’-二甲氧基-4,4’-二胺基联苯、1,4-双(4’-胺基苯基)苯或上述化合物的组合。Specific examples of the compound represented by formula (II-3) preferably include p-diaminobenzene, 2,5-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'-dimethyl Oxy-4,4'-diaminobiphenyl, 1,4-bis(4'-aminophenyl)benzene or a combination of the above compounds.
式(II-4)中,v表示2至12的整数。In formula (II-4), v represents an integer of 2 to 12.
式(II-5)中,w表示1至5的整数。由式(II-5)表示的化合物较佳为4,4’-二胺基-二苯基硫醚。In formula (II-5), w represents an integer of 1 to 5. The compound represented by formula (II-5) is preferably 4,4'-diamino-diphenylsulfide.
式(II-6)中,B7及B9各自独立表示二价有机基团,且B7及B9可为相同或不同;B8表示衍生自吡啶、嘧啶、三嗪、呱啶或呱嗪等含氮原子的环状结构的二价基团。In formula (II-6), B 7 and B 9 each independently represent a divalent organic group, and B 7 and B 9 can be the same or different; B 8 represents a group derived from pyridine, pyrimidine, triazine, piperidine or piperidine A divalent group with a ring structure containing a nitrogen atom such as oxazine.
式(II-7)中,B10、B11、B12及B13各自独立表示碳数为1至12的烃基,且B10、B11、B12及B13可为相同或不同;X1各自独立表示1至3的整数;X2表示1至20的整数。In formula (II-7), B 10 , B 11 , B 12 and B 13 each independently represent a hydrocarbon group with a carbon number of 1 to 12, and B 10 , B 11 , B 12 and B 13 may be the same or different; X1 Each independently represents an integer of 1 to 3; X2 represents an integer of 1 to 20.
式(II-8)中,B14表示氧原子或亚环己烷基;B15表示亚甲基(methylene,-CH2-);B16表示亚苯基或亚环己烷基;B17表示氢原子或庚基。In formula (II-8), B 14 represents an oxygen atom or a cyclohexylene group; B 15 represents a methylene group (methylene, -CH 2 -); B 16 represents a phenylene group or a cyclohexylene group; B 17 represents a hydrogen atom or a heptyl group.
由式(II-8)表示的化合物的具体例包括由式(II-8-1)表示的化合物、由式(II-8-2)表示的化合物或上述化合物的组合。Specific examples of the compound represented by formula (II-8) include a compound represented by formula (II-8-1), a compound represented by formula (II-8-2), or a combination of the above compounds.
由式(II-9)至式(II-30)表示的化合物如下所示。Compounds represented by formula (II-9) to formula (II-30) are shown below.
式(II-17)至式(II-25)中,B18较佳为表示碳数为1至10的烷基或碳数为1至10的烷氧基;B19较佳为表示氢原子、碳数为1至10的烷基或碳数为1至10的烷氧基。In formula (II-17) to formula (II-25), B 18 preferably represents an alkyl group with a carbon number of 1 to 10 or an alkoxy group with a carbon number of 1 to 10; B 19 preferably represents a hydrogen atom , an alkyl group having 1 to 10 carbons or an alkoxy group having 1 to 10 carbons.
二胺化合物(b-2)可单独使用或组合多种来使用。The diamine compound (b-2) can be used individually or in combination of several types.
二胺化合物(b-2)的具体例较佳为包括但不限于1,2-二胺基乙烷、4,4’-二胺基二环己基甲烷、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、5-[4-(4-正戊烷基环己基)环己基]苯基亚甲基-1,3-二胺基苯、1,1-双[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)环己烷、2,4-二胺基苯基甲酸乙酯、1-十八烷氧基-2,4-二胺基苯、由式(II-1-1)表示的化合物、由式(II-1-2)表示的化合物、由式(II-1-4)表示的化合物、由式(II-1-5)表示的化合物、由式(II-2-1)表示的化合物、由式(II-2-11)表示的化合物、对-二胺苯、间-二胺苯、邻-二胺苯、由式(II-8-1)表示的化合物、由式(II-26)至式(II-30)表示的化合物,或上述化合物的组合。Specific examples of diamine compounds (b-2) preferably include, but are not limited to, 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminobis Phenylmethane, 4,4'-diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, ethyl 2,4-diaminophenylcarboxylate, 1- Octadecyloxy-2,4-diaminobenzene, a compound represented by formula (II-1-1), a compound represented by formula (II-1-2), a compound represented by formula (II-1-4) Compounds represented by formula (II-1-5), compounds represented by formula (II-2-1), compounds represented by formula (II-2-11), p-diaminobenzene, meta - Diaminobenzene, o-diaminobenzene, a compound represented by formula (II-8-1), a compound represented by formula (II-26) to formula (II-30), or a combination of the above compounds.
基于二胺组分(b)的使用量为100摩尔,二胺化合物(b-2)的使用量可为80摩尔至97摩尔,较佳为82摩尔至96摩尔,且更佳为85摩尔至95摩尔。Based on the usage amount of diamine component (b) being 100 moles, the usage amount of diamine compound (b-2) can be 80 moles to 97 moles, preferably 82 moles to 96 moles, and more preferably 85 moles to 95 moles.
当液晶配向剂中聚合物(A)含有式(II-1)、式(II-2)、式(II-26)至式(II-30)表示的二胺化合物(b-2)中的至少一种时,可进一步提升液晶显示组件的紫外线可靠性。When the polymer (A) in the liquid crystal alignment agent contains the diamine compound (b-2) represented by formula (II-1), formula (II-2), formula (II-26) to formula (II-30) When at least one kind is used, the ultraviolet reliability of the liquid crystal display component can be further improved.
制备聚合物(A)的方法Process for preparing polymer (A)
聚合物(A)可包括聚酰胺酸及聚酰亚胺中的至少一种。另外,聚合物(A)可还包括聚酰亚胺系嵌段共聚合物。以下进一步说明上述各种聚合物的制备方法。The polymer (A) may include at least one of polyamic acid and polyimide. In addition, the polymer (A) may further include a polyimide-based block copolymer. The preparation methods of the above-mentioned various polymers are further described below.
制备聚酰胺酸的方法Method for preparing polyamic acid
制备聚酰胺酸的方法为先将混合物溶解于溶剂中,其中混合物包括四羧酸二酐组分(a)与二胺组分(b),并在0℃至100℃的温度下进行聚缩合反应。反应1小时至24小时后,以蒸发器对反应溶液进行减压蒸馏,即可得到聚酰胺酸。或者,将反应溶液倒入大量的贫溶剂中,以得到析出物。接着,以减压干燥的方式干燥析出物,即可得到聚酰胺酸。The method for preparing polyamic acid is to first dissolve the mixture in a solvent, wherein the mixture includes tetracarboxylic dianhydride component (a) and diamine component (b), and carry out polycondensation at a temperature of 0°C to 100°C reaction. After reacting for 1 hour to 24 hours, the reaction solution is distilled under reduced pressure with an evaporator to obtain polyamic acid. Alternatively, the reaction solution is poured into a large amount of poor solvent to obtain a precipitate. Then, the precipitate is dried under reduced pressure to obtain polyamic acid.
用于聚缩合反应中的溶剂可与下述液晶配向剂中的溶剂相同或不同,且用于聚缩合反应中的溶剂并无特别的限制,只要是可溶解反应物与生成物即可。溶剂较佳为包括但不限于(1)非质子系极性溶剂,例如:N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidinone,简称NMP)、N,N-二甲基乙酰胺、N,N-二甲基甲酰胺、二甲基亚砜、γ-丁内酯、四甲基尿素或六甲基磷酸三胺等的非质子系极性溶剂;或(2)酚系溶剂,例如:间-甲酚、二甲苯酚、酚或卤化酚类等的酚系溶剂。基于混合物的总使用量为100重量份,用于聚缩合反应中的溶剂的使用量较佳为200重量份至2000重量份,且更佳为300重量份至1800重量份。The solvent used in the polycondensation reaction may be the same as or different from the solvent in the liquid crystal alignment agent described below, and the solvent used in the polycondensation reaction is not particularly limited as long as it can dissolve the reactants and products. The solvents preferably include but are not limited to (1) aprotic polar solvents, such as: N-methyl-2-pyrrolidinone (N-methyl-2-pyrrolidinone, NMP for short), N,N-dimethylacetamide , N,N-dimethylformamide, dimethyl sulfoxide, γ-butyrolactone, tetramethylurea or hexamethylphosphoric triamine and other aprotic polar solvents; or (2) phenolic solvents , For example: phenolic solvents such as m-cresol, xylenol, phenol or halogenated phenols. Based on 100 parts by weight of the total mixture, the solvent used in the polycondensation reaction is preferably used in an amount of 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight.
值得注意的是,在聚缩合反应中,溶剂可并用适量的贫溶剂,其中贫溶剂不会造成聚酰胺酸析出。贫溶剂可以使用单独一种或者组合多种来使用,且其包括但不限于(1)醇类,例如:甲醇、乙醇、异丙醇、环己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等的醇类;(2)酮类,例如:丙酮、甲基乙基酮、甲基异丁基酮、环己酮等的酮类;(3)酯类,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或乙二醇乙基醚醋酸酯等的酯类;(4)醚类,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇异丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基醚等的醚类;(5)卤化烃类,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯或邻-二氯苯等的卤化烃类;或(6)烃类,例如:四氢呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲苯等的烃类或上述溶剂的任意组合。基于二胺组分(b)的使用量为100重量份,贫溶剂的用量较佳为0重量份至60重量份,且更佳为0重量份至50重量份。It should be noted that in the polycondensation reaction, the solvent can be combined with an appropriate amount of poor solvent, and the poor solvent will not cause the precipitation of polyamic acid. Poor solvents can be used alone or in combination, and they include but are not limited to (1) alcohols, such as: methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4- Alcohols such as butylene glycol or triethylene glycol; (2) ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.; (3) esters, For example: esters of methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate or ethylene glycol ethyl ether acetate; (4) ethers, such as: diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, or diethylene glycol Ethers such as dimethyl ether; (5) halogenated hydrocarbons, such as dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene or o- Halogenated hydrocarbons such as dichlorobenzene; or (6) hydrocarbons, such as tetrahydrofuran, hexane, heptane, octane, benzene, toluene or xylene or any combination of the above solvents. Based on 100 parts by weight of the diamine component (b), the amount of the poor solvent is preferably 0 to 60 parts by weight, and more preferably 0 to 50 parts by weight.
制备聚酰亚胺的方法Method for preparing polyimide
制备聚酰亚胺的方法为将上述制备聚酰胺酸的方法所制的聚酰胺酸在脱水剂及触媒的存在下进行加热而得。在加热过程中,聚酰胺酸中的酰胺酸官能基可通过脱水死循环反应转变成酰亚胺官能基(即酰亚胺化)。The method for preparing polyimide is obtained by heating the polyamic acid prepared by the above method for preparing polyamic acid in the presence of a dehydrating agent and a catalyst. During the heating process, the amic acid functional group in the polyamic acid can be converted into an imide functional group through a dehydration dead cycle reaction (ie, imidization).
用于脱水死循环反应中的溶剂可与液晶配向剂中的溶剂(B)相同,故在此不另赘述。基于聚酰胺酸的使用量为100重量份,用于脱水死循环反应中的溶剂的使用量较佳为200重量份至2000重量份,且更佳为300重量份至1800重量份。The solvent used in the dehydration dead cycle reaction can be the same as the solvent (B) in the liquid crystal alignment agent, so it will not be repeated here. Based on the amount of polyamic acid used as 100 parts by weight, the amount of solvent used in the dehydration dead cycle reaction is preferably 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight.
为获得较佳的聚酰胺酸的酰亚胺化程度,脱水死循环反应的操作温度较佳为40℃至200℃,更佳为40℃至150℃。若脱水死循环反应的操作温度低于40℃时,酰亚胺化的反应不完全,而降低聚酰胺酸的酰亚胺化程度。然而,若脱水死循环反应的操作温度高于200℃时,所得的聚酰亚胺的重量平均分子量偏低。In order to obtain a better degree of imidization of the polyamic acid, the operating temperature of the dead cycle dehydration reaction is preferably from 40°C to 200°C, more preferably from 40°C to 150°C. If the operating temperature of the dehydration dead cycle reaction is lower than 40° C., the imidization reaction will not be complete, and the degree of imidization of the polyamic acid will be reduced. However, if the operating temperature of the dehydration dead cycle reaction is higher than 200° C., the weight average molecular weight of the obtained polyimide is low.
用于脱水死循环反应中的脱水剂可选自于酸酐类化合物,其具体例如:醋酸酐、丙酸酐或三氟醋酸酐等的酸酐类化合物。基于聚酰胺酸为1摩尔,脱水剂的使用量为0.01摩尔至20摩尔。用于脱水死循环反应中的触媒可选自于(1)吡啶类化合物,例如:吡啶、三甲基吡啶或二甲基吡啶等的吡啶类化合物;(2)三级胺类化合物,例如:三乙基胺等的三级胺类化合物。基于脱水剂的使用量为1摩尔,触媒的使用量可为0.5摩尔至10摩尔。The dehydrating agent used in the dehydration dead cycle reaction can be selected from acid anhydride compounds, for example, acid anhydride compounds such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride. Based on 1 mole of the polyamic acid, the amount of the dehydrating agent is 0.01 mole to 20 mole. The catalyst used in the dehydration dead cycle reaction can be selected from (1) pyridine compounds, such as: pyridine compounds such as pyridine, collidine or lutidine; (2) tertiary amine compounds, such as: Tertiary amine compounds such as triethylamine. Based on 1 mole of the dehydrating agent, the catalyst can be used in an amount of 0.5 moles to 10 moles.
聚合物(A)的酰亚胺化率可为30%至90%,较佳为35%至85%,且更佳为40%至80%。当液晶配向剂中聚合物(A)的酰亚胺化率在上述范围内时,可进一步提升所形成的液晶配向膜的紫外线可靠性。The imidization rate of the polymer (A) may be 30% to 90%, preferably 35% to 85%, and more preferably 40% to 80%. When the imidization rate of the polymer (A) in the liquid crystal alignment agent is within the above range, the UV reliability of the formed liquid crystal alignment film can be further improved.
制备聚酰亚胺系嵌段共聚合物的方法Method for preparing polyimide-based block copolymers
聚酰亚胺系嵌段共聚合物为选自聚酰胺酸嵌段共聚合物、聚酰亚胺嵌段共聚合物、聚酰胺酸-聚酰亚胺嵌段共聚合物或上述聚合物的任意组合。Polyimide block copolymer is selected from polyamic acid block copolymer, polyimide block copolymer, polyamic acid-polyimide block copolymer or the above-mentioned polymer random combination.
制备聚酰亚胺系嵌段共聚合物的方法较佳为先将起始物溶解于溶剂中,并进行聚缩合反应,其中起始物包括至少一种聚酰胺酸和/或至少一种聚酰亚胺,且可进一步包括羧酸酐组分与二胺组分。The method for preparing polyimide-based block copolymers is preferably to first dissolve the starting material in a solvent, and carry out polycondensation reaction, wherein the starting material includes at least one polyamic acid and/or at least one polyamic acid imide, and may further include a carboxylic anhydride component and a diamine component.
起始物中的羧酸酐组分与二胺组分可与制备聚酰胺酸的方法中所使用的四羧酸二酐组分(a)与二胺组分(b)相同,且用于聚缩合反应中的溶剂可与下述液晶配向剂中的溶剂相同,在此不另赘述。The carboxylic anhydride component and the diamine component in the starter can be the same as the tetracarboxylic dianhydride component (a) and the diamine component (b) used in the method for preparing polyamic acid, and used for polyamic acid The solvent in the condensation reaction may be the same as the solvent in the liquid crystal alignment agent described below, which will not be repeated here.
基于起始物的使用量为100重量份,用于聚缩合反应中的溶剂的使用量较佳为200重量份至2000重量份,且更佳为300重量份至1800重量份。聚缩合反应的操作温度较佳为0℃至200℃,且更佳为0℃至100℃。Based on 100 parts by weight of the starting material, the solvent used in the polycondensation reaction is preferably used in an amount of 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight. The operating temperature of the polycondensation reaction is preferably from 0°C to 200°C, and more preferably from 0°C to 100°C.
起始物较佳为包括但不限于(1)二种末端基相异且结构相异的聚酰胺酸;(2)二种末端基相异且结构相异的聚酰亚胺;(3)末端基相异且结构相异的聚酰胺酸及聚酰亚胺;(4)聚酰胺酸、羧酸酐组分与二胺组分,其中,羧酸酐组分与二胺组分之中的至少一种与形成聚酰胺酸所使用的羧酸酐组分与二胺组分的结构相异;(5)聚酰亚胺、羧酸酐组分与二胺组分,其中,羧酸酐组分与二胺组分中的至少一种与形成聚酰亚胺所使用的羧酸酐组分与二胺组分的结构相异;(6)聚酰胺酸、聚酰亚胺、羧酸酐组分与二胺组分,其中,羧酸酐组分与二胺组分中的至少一种与形成聚酰胺酸或聚酰亚胺所使用的羧酸酐组分与二胺组分的结构相异;(7)二种结构相异的聚酰胺酸、羧酸酐组分与二胺组分;(8)二种结构相异的聚酰亚胺、羧酸酐组分与二胺组分;(9)二种末端基为酸酐基且结构相异的聚酰胺酸以及二胺组分;(10)二种末端基为胺基且结构相异的聚酰胺酸以及羧酸酐组分;(11)二种末端基为酸酐基且结构相异的聚酰亚胺以及二胺组分;或者(12)二种末端基为胺基且结构相异的聚酰亚胺以及羧酸酐组分。The starting material preferably includes but is not limited to (1) two kinds of polyamic acids with different end groups and different structures; (2) two kinds of polyimides with different end groups and different structures; (3) Polyamic acid and polyimide with different terminal groups and different structures; (4) polyamic acid, carboxylic anhydride component and diamine component, wherein at least one of the carboxylic anhydride component and the diamine component One is different from the structure of the carboxylic anhydride component and the diamine component used to form polyamic acid; (5) polyimide, carboxylic anhydride component and diamine component, wherein, the carboxylic anhydride component and the diamine component At least one of the amine components is different from the structure of the carboxylic anhydride component and the diamine component used to form the polyimide; (6) polyamic acid, polyimide, carboxylic anhydride component and diamine Components, wherein at least one of the carboxylic anhydride component and the diamine component is different from the structure of the carboxylic anhydride component and the diamine component used to form polyamic acid or polyimide; (7) two (8) Two kinds of polyimides, carboxylic anhydride components and diamine components with different structures; (9) Two kinds of terminal groups Anhydride-based polyamic acid and diamine components with different structures; (10) two kinds of polyamic acid and carboxylic anhydride components with amine-based terminal groups and different structures; (11) two kinds of terminal groups with acid anhydride or (12) two kinds of polyimide and carboxylic acid anhydride components whose terminal groups are amine groups and have different structures.
在不影响本发明的功效的范围内,聚酰胺酸、聚酰亚胺以及聚酰亚胺系嵌段共聚合物较佳为先进行分子量调节后的末端修饰型聚合物。通过使用末端修饰型的聚合物,可改善液晶配向剂的涂布性能。制备末端修饰型聚合物的方式可通过在聚酰胺酸进行聚缩合反应的同时,加入单官能性化合物来制得。The polyamic acid, polyimide, and polyimide-based block copolymers are preferably end-modified polymers that have been first adjusted in molecular weight within the range that does not affect the efficacy of the present invention. By using terminal-modified polymers, the coating performance of the liquid crystal alignment agent can be improved. The method of preparing the end-modified polymer can be obtained by adding a monofunctional compound while the polyamic acid undergoes polycondensation reaction.
单官能性化合物的具体例包括但不限于(1)一元酸酐,例如:马来酸酐、邻苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等一元酸酐;(2)单胺化合物,例如:苯胺、环己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等单胺化合物;或(3)单异氰酸酯化合物,例如:异氰酸苯酯或异氰酸萘基酯等单异氰酸酯化合物。Specific examples of monofunctional compounds include but are not limited to (1) monobasic acid anhydrides, such as: maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl anhydride, Monobasic acid anhydrides such as alkyl succinic anhydride or n-hexadecyl succinic anhydride; (2) Monoamine compounds, such as: aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, Monoamine compounds such as n-octadecylamine or n-eicosylamine; or (3) monoisocyanate compounds, such as monoisocyanate compounds such as phenyl isocyanate or naphthyl isocyanate.
溶劑(B)solvent (B)
本发明的液晶配向剂中所使用的溶剂并无特别的限制,只要是可溶解聚合物(A)与其它任意成分且并不与其产生反应即可,较佳为同前述合成聚酰胺酸中所使用的溶剂,同时,也可并用合成该聚酰胺酸时所使用的贫溶剂。The solvent used in the liquid crystal alignment agent of the present invention is not particularly limited, as long as it can dissolve the polymer (A) and any other components and does not react with it. The solvent used may also use together the poor solvent used at the time of synthesizing this polyamic acid at the same time.
溶剂(B)的具体例包括但不限于N-甲基-2-吡咯烷酮、γ-丁内酯、γ-丁内酰胺、4-羟基-4-甲基-2-戊酮、乙二醇单甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇异丙基醚、乙二醇正丁基醚(ethylene glycol n-butyl ether)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二乙二醇二甲基醚、二乙二醇二乙基醚、二乙二醇单甲基醚、二乙二醇单乙基醚、二乙二醇单甲基醚乙酸酯、二乙二醇单乙基醚乙酸酯或N,N-二甲基甲酰胺或N,N-二甲基乙酰胺(N,N-dimethylacetamide)等。溶剂(B)可以单独使用或者组合多种来使用。Specific examples of the solvent (B) include, but are not limited to, N-methyl-2-pyrrolidone, γ-butyrolactone, γ-butyrolactam, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol mono Methyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethyl Glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol dimethyl ether, Ethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate or N,N-dimethylformamide or N,N-dimethylacetamide (N,N-dimethylacetamide), etc. The solvent (B) can be used individually or in combination of multiple types.
基于聚合物(A)的使用量为100重量份,溶剂(B)的使用量为800至4000重量份,较佳为900至3500重量份,且更佳为1000至3000重量份。Based on 100 parts by weight of the polymer (A), the used amount of the solvent (B) is 800 to 4000 parts by weight, preferably 900 to 3500 parts by weight, and more preferably 1000 to 3000 parts by weight.
添加剂(C)Additive (C)
在不影响本发明的功效的范围内,液晶配向剂还可选择性地添加添加剂(C),其中添加剂(C)包括具有至少两个环氧基的化合物、具有官能性基团的硅烷化合物,或其组合。In the range that does not affect the effectiveness of the present invention, the liquid crystal alignment agent can optionally add additives (C), wherein the additives (C) include compounds with at least two epoxy groups, silane compounds with functional groups, or a combination thereof.
具有至少两个环氧基的化合物包括但不限于乙二醇二环氧丙基醚、聚乙二醇二环氧丙基醚、丙二醇二环氧丙基醚、三丙二醇二环氧丙基醚、聚丙二醇二环氧丙基醚、新戊二醇二环氧丙基醚、1,6-己二醇二环氧丙基醚、丙三醇二环氧丙基醚、2,2-二溴新戊二醇二环氧丙基醚、1,3,5,6-四环氧丙基-2,4-己二醇、N,N,N’,N’-四环氧丙基-间-二甲苯二胺、1,3-双(N,N-二环氧丙基胺基甲基)环己烷、N,N,N’,N’-四环氧丙基-4,4’-二胺基二苯基甲烷、3-(N,N-二环氧丙基)胺基丙基三甲氧基硅烷,或上述化合物的组合。Compounds having at least two epoxy groups include, but are not limited to, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether , Polypropylene Glycol Diglycidyl Ether, Neopentyl Glycol Diglycidyl Ether, 1,6-Hexanediol Diglycidyl Ether, Glycerol Diglycidyl Ether, 2,2-Di Bromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraepoxypropyl-2,4-hexanediol, N,N,N',N'-tetraepoxypropyl- m-Xylylenediamine, 1,3-bis(N,N-diepoxypropylaminomethyl)cyclohexane, N,N,N',N'-tetraepoxypropyl-4,4 '-diaminodiphenylmethane, 3-(N,N-diepoxypropyl)aminopropyltrimethoxysilane, or a combination of the above compounds.
具有至少两个环氧基的化合物可单独使用或组合多种来使用。The compound which has at least two epoxy groups can be used individually or in combination of several types.
基于聚合物(A)的使用量为100重量份,具有至少两个环氧基的化合物的使用量可为0至40重量份,且较佳为0.1重量份至30重量份。Based on 100 parts by weight of the polymer (A), the compound having at least two epoxy groups may be used in an amount of 0 to 40 parts by weight, and preferably 0.1 to 30 parts by weight.
具有官能性基团的硅烷化合物的具体例包括但不限于3-胺基丙基三甲氧基硅烷、3-胺基丙基三乙氧基硅烷、2-胺基丙基三甲氧基硅烷、2-胺基丙基三乙氧基硅烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基硅烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基硅烷、3-脲基丙基三甲氧基硅烷(3-ureidopropyltrimethoxy silane)、3-脲基丙基三乙氧基硅烷、N-乙氧基羰基-3-胺基丙基三甲氧基硅烷、N-乙氧基羰基-3-胺基丙基三乙氧基硅烷、N-三乙氧基硅烷基丙基三伸乙三胺、N-三甲氧基硅烷基丙基三伸乙三胺、10-三甲氧基硅烷基-1,4,7-三吖癸烷、10-三乙氧基硅烷基-1,4,7-三吖癸烷、9-三甲氧基硅烷基-3,6-二吖壬基醋酸酯、9-三乙氧基硅烷基-3,6-二吖壬基醋酸酯、N-芐基-3-胺基丙基三甲氧基硅烷、N-芐基-3-胺基丙基三乙氧基硅烷、N-苯基-3-胺基丙基三甲氧基硅烷、N-苯基-3-胺基丙基三乙氧基硅烷、N-双(氧化乙烯)-3-胺基丙基三甲氧基硅烷、N-双(氧化乙烯)-3-胺基丙基三乙氧基硅烷,或上述化合物的组合。Specific examples of silane compounds having functional groups include, but are not limited to, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltrimethoxysilane, -Aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropyl Methyldimethoxysilane, 3-ureidopropyltrimethoxysilane (3-ureidopropyltrimethoxy silane), 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyl Trimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyltri Ethylenetriamine, 10-trimethoxysilyl-1,4,7-triazidecane, 10-triethoxysilyl-1,4,7-triazidecane, 9-trimethoxysilane -3,6-diazinonyl acetate, 9-triethoxysilyl-3,6-diazinonyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N -Benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N - bis(oxyethylene)-3-aminopropyltrimethoxysilane, N-bis(oxyethylene)-3-aminopropyltriethoxysilane, or a combination of the aforementioned compounds.
具有官能性基团的硅烷化合物可以单独使用或组合多种来使用。The silane compound which has a functional group can be used individually or in combination of several types.
基于聚合物(A)的使用量为100重量份,具有官能性基团的硅烷化合物的使用量可为0至10重量份,且较佳为0.5重量份至10重量份。Based on 100 parts by weight of the polymer (A), the amount of the silane compound having a functional group may be 0 to 10 parts by weight, and preferably 0.5 to 10 parts by weight.
基于聚合物(A)的总使用量为100重量份,添加剂(C)的使用量较佳为0.5重量份至50重量份,且更佳为1重量份至45重量份。The additive (C) is preferably used in an amount of 0.5 to 50 parts by weight, and more preferably 1 to 45 parts by weight, based on 100 parts by weight of the total polymer (A).
<液晶配向剂的制备方法><Preparation method of liquid crystal alignment agent>
液晶配向剂的制备方法并无特别的限制,可采用一般的混合方法来制备。举例而言,先将聚合物(A)于温度为0℃至200℃的条件下加入溶剂(B)中,并且选择性地添加添加剂(C)。接着,使用搅拌装置持续搅拌至溶解即可。此外,另外,较佳的是在20℃至60℃的温度下添加溶剂(B)。The preparation method of the liquid crystal alignment agent is not particularly limited, and a general mixing method can be used for preparation. For example, the polymer (A) is first added to the solvent (B) at a temperature of 0° C. to 200° C., and the additive (C) is optionally added. Next, use a stirring device to continue stirring until it dissolves. Furthermore, additionally, it is preferable to add the solvent (B) at a temperature of 20°C to 60°C.
<液晶配向膜的制备方法><Manufacturing Method of Liquid Crystal Alignment Film>
本发明的液晶配向膜可由上述的液晶配向剂而形成。The liquid crystal alignment film of the present invention can be formed from the above-mentioned liquid crystal alignment agent.
具体而言,液晶配向膜的制备方式例如可以是:将液晶配向剂利用辊涂布法、旋转涂布法、印刷法或喷墨法(ink-jet)等方法,涂布在基板的表面上,形成预涂层。接着,对预涂层进行预烘烤处理(pre-bake treatment)、后烘烤处理(post-bake treatment)及配向处理(alignment treatment)后而制得形成了液晶配向膜的基板。Specifically, the preparation method of the liquid crystal alignment film may be, for example: coating the liquid crystal alignment agent on the surface of the substrate by roll coating method, spin coating method, printing method or ink-jet method. , forming a precoat. Next, pre-bake treatment, post-bake treatment, and alignment treatment are performed on the pre-coat layer to obtain a substrate on which a liquid crystal alignment film is formed.
预烘烤处理的目的在于使预涂层中的有机溶剂挥发。预烘烤处理的操作温度较佳为30℃至120℃,且更佳为40℃至110℃,尤佳为50℃至100℃。The purpose of the pre-baking treatment is to volatilize the organic solvent in the pre-coating. The operating temperature of the pre-baking treatment is preferably from 30°C to 120°C, more preferably from 40°C to 110°C, and especially preferably from 50°C to 100°C.
配向处理并无特别的限制,可将尼龙、人造丝或棉类等纤维所做成的布料缠绕在滚筒上,并以一定方向摩擦进行配向。There is no special limitation on the alignment treatment, and the cloth made of fibers such as nylon, rayon or cotton can be wound on the drum and rubbed in a certain direction for alignment.
后烘烤处理步骤的目的在于使预涂层中的聚合物再进一步进行脱水死循环(酰亚胺化)反应。后烘烤处理的操作温度较佳为150℃至300℃,更佳为180℃至280℃,尤佳为200℃至250℃。The purpose of the post-baking treatment step is to make the polymer in the pre-coating layer further undergo a dead cycle dehydration (imidization) reaction. The operating temperature of the post-baking treatment is preferably from 150°C to 300°C, more preferably from 180°C to 280°C, and especially preferably from 200°C to 250°C.
<液晶显示组件及其制备方法><Liquid crystal display module and manufacturing method thereof>
本发明的液晶显示组件包括由本发明的液晶配向剂所形成的液晶配向膜。本发明的液晶显示组件可以如下述方法制造。The liquid crystal display component of the present invention includes a liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention. The liquid crystal display module of the present invention can be manufactured as follows.
准备两片如上述形成了液晶配向膜的基板,并在这两片基板间配置液晶,并制造液晶胞。为了制造液晶胞(cell),可以列举例如以下两种方法。Prepare two substrates on which the liquid crystal alignment film is formed as described above, arrange liquid crystal between the two substrates, and manufacture a liquid crystal cell. In order to manufacture a liquid crystal cell (cell), the following two methods are mentioned, for example.
第一种方法:首先,将两片基板隔着间隙(胞间隙)相对配置,使各自的液晶配向膜相对向;使用密封剂将两片基板的周边部位贴合在一起;向由基板表面和密封剂所划分的胞间隙内注入填充液晶;并且封闭注入孔,如此可以制造液晶胞。The first method: first, two substrates are arranged oppositely across a gap (intercellular gap), so that their respective liquid crystal alignment films face each other; the peripheral parts of the two substrates are bonded together using a sealant; Liquid crystal is injected into the intercellular space divided by the sealant; and the injection hole is closed, so that the liquid crystal cell can be manufactured.
第二种方法:被称作为滴注(One Drop Fill,简称ODF)方式的方法。首先,在形成液晶配向膜的两片基板中的一片基板上的规定部位,涂布例如紫外线固化性密封材料;在液晶配向膜面上滴下液晶;然后,贴合另一片基板,使液晶配向膜相对向;接着,对基板整面照射紫外线,以使密封剂固化,藉此可以制造液晶胞。The second method: a method called the One Drop Fill (ODF for short) method. First of all, on a predetermined position on one of the two substrates forming the liquid crystal alignment film, for example, an ultraviolet curable sealing material is coated; liquid crystal is dropped on the surface of the liquid crystal alignment film; then, the other substrate is bonded to make the liquid crystal alignment film facing each other; next, the entire surface of the substrate is irradiated with ultraviolet light to cure the sealant, whereby a liquid crystal cell can be manufactured.
在采用上述任一方法的情况下,都希望接着将液晶胞加热至所用液晶呈各向同性相的温度后,缓慢冷却至室温,藉此除去填充液晶时的流动配向。In the case of using any of the above methods, it is desirable to heat the liquid crystal cell to the temperature at which the liquid crystal used is in the isotropic phase, and then slowly cool it to room temperature, thereby removing the flow alignment when filling the liquid crystal.
然后,通过在液晶胞的外侧表面上贴合偏光板(polarizer),由此可以得到本发明的液晶显示组件。Then, the liquid crystal display module of the present invention can be obtained by attaching a polarizer to the outer surface of the liquid crystal cell.
密封剂例如可使用含有固化剂和作为间隔物(spacer)的氧化铝球的环氧树脂等。As the sealing agent, for example, an epoxy resin containing a curing agent and alumina balls as spacers can be used.
液晶胞外侧使用的偏光板可以列举用乙酸纤维素(cellulose acetate)保护膜夹住使聚乙烯醇(polyvinyl alcohol)拉伸配向的同时吸收碘所得的称作为“H膜”的偏光膜(polarizing film)而形成的偏光板或者H膜自身所形成的偏光板。The polarizing plate used on the outside of the liquid crystal cell includes a polarizing film called a "H film" obtained by sandwiching polyvinyl alcohol (polyvinyl alcohol) stretch alignment with cellulose acetate protective films and absorbing iodine. ) to form a polarizer or a polarizer formed by the H film itself.
如此制造的本发明的液晶显示组件,其显示性能优良,并且即使长时间使用,显示性能也不会变差。The liquid crystal display module of the present invention manufactured in this way has excellent display performance, and the display performance will not deteriorate even if it is used for a long time.
图1是本发明一实施例的液晶显示组件的侧视图。液晶显示组件100包括第一单元110、第二单元120及液晶单元130,其中第二单元120与第一单元110分离配置,且液晶单元130设置在第一单元110与第二单元120之间。FIG. 1 is a side view of a liquid crystal display module according to an embodiment of the present invention. The liquid crystal display assembly 100 includes a first unit 110 , a second unit 120 and a liquid crystal unit 130 , wherein the second unit 120 is disposed separately from the first unit 110 , and the liquid crystal unit 130 is disposed between the first unit 110 and the second unit 120 .
第一单元110包括第一基板112、第一导电膜114及第一液晶配向膜116,其中第一导电膜114位于第一基板112与第一液晶配向膜116之间,并且第一液晶配向膜116位于液晶单元130的一侧。The first unit 110 includes a first substrate 112, a first conductive film 114, and a first liquid crystal alignment film 116, wherein the first conductive film 114 is located between the first substrate 112 and the first liquid crystal alignment film 116, and the first liquid crystal alignment film 116 is located on one side of the liquid crystal cell 130 .
第二单元120包括第二基板122、第二导电膜124及第二液晶配向膜126,其中第二导电膜124位于第二基板122与第二液晶配向膜126之间,并且第二液晶配向膜126位于液晶单元130的另一侧。换言之,液晶单元130是位于第一液晶配向膜116与第二液晶配向膜126之间。The second unit 120 includes a second substrate 122, a second conductive film 124, and a second liquid crystal alignment film 126, wherein the second conductive film 124 is located between the second substrate 122 and the second liquid crystal alignment film 126, and the second liquid crystal alignment film 126 is located on the other side of the liquid crystal cell 130 . In other words, the liquid crystal unit 130 is located between the first liquid crystal alignment film 116 and the second liquid crystal alignment film 126 .
第一基板112与第二基板122是选自于透明材料等,其中,透明材料包括但不限于用于液晶显示装置的无碱玻璃、钠钙玻璃、硬质玻璃(派勒斯玻璃)、石英玻璃、聚乙烯对苯二甲酸酯、聚丁烯、对苯二甲酸酯、聚醚砜或聚碳酸酯等。第一导电膜114与第二导电膜124的材质是择自于氧化锡(SnO2)、氧化铟-氧化锡(In2O3-SnO2)等。The first substrate 112 and the second substrate 122 are selected from transparent materials, etc., wherein the transparent materials include but not limited to alkali-free glass, soda-lime glass, hard glass (Pyles glass), quartz, etc. used in liquid crystal display devices. Glass, polyethylene terephthalate, polybutylene, terephthalate, polyethersulfone or polycarbonate, etc. The materials of the first conductive film 114 and the second conductive film 124 are selected from tin oxide (SnO 2 ), indium oxide-tin oxide (In 2 O 3 —SnO 2 ), and the like.
第一液晶配向膜116及第二液晶配向膜126各自为上述的液晶配向膜,其作用在于使液晶单元130形成预倾角。此外,当施加第一导电膜114与第二导电膜124电压时,第一导电膜114与第二导电膜124之间可产生电场。此电场可驱动液晶单元130,进而使液晶单元130中的液晶分子的排列发生改变。液晶单元130所使用的液晶可单独使用或混合使用,液晶包括但不限于二胺基苯类液晶、哒嗪(pyridazine)类液晶、希夫氏碱(shiff Base)类液晶、氧化偶氮基(azoxy)类液晶、联苯(biphenyl)类液晶、苯基环己烷(phenylcyclohexane)类液晶、酯(ester)类液晶、三联苯(terphenyl)、联苯环己烷(biphenylcyclohexane)类液晶、嘧啶(pyrimidine)类液晶、二氧六环(dioxane)类液晶、双环辛烷(bicyclooctane)类液晶或立方烷(cubane)类液晶等,且可视需求再添加例如是氯化胆固醇(cholesterylchloride)、胆固醇壬酸酯(cholesteryl nonanoate)、胆固醇碳酸酯(cholesterylcarbonate)等的胆固醇型液晶、或是以商品名“C-15”、“CB-15”(默克公司制造)的对掌(chiral)剂等,或者是对癸氧基苯亚甲基-对胺基-2-甲基丁基肉桂酸酯等强介电性(ferroelectric)类液晶。The first liquid crystal alignment film 116 and the second liquid crystal alignment film 126 are each the above-mentioned liquid crystal alignment film, and their function is to make the liquid crystal unit 130 form a pre-tilt angle. In addition, when a voltage is applied to the first conductive film 114 and the second conductive film 124 , an electric field may be generated between the first conductive film 114 and the second conductive film 124 . The electric field can drive the liquid crystal unit 130 , thereby changing the arrangement of the liquid crystal molecules in the liquid crystal unit 130 . The liquid crystals used in the liquid crystal unit 130 can be used alone or in combination, and the liquid crystals include but are not limited to diaminobenzene liquid crystals, pyridazine (pyridazine) liquid crystals, Schiff Base (shiff Base) liquid crystals, azoxy ( azoxy) liquid crystals, biphenyl liquid crystals, phenylcyclohexane liquid crystals, ester liquid crystals, terphenyl, biphenylcyclohexane liquid crystals, pyrimidine ( pyrimidine-based liquid crystals, dioxane-based liquid crystals, bicyclooctane-based liquid crystals, or cubane-based liquid crystals, etc. Cholesteryl liquid crystals such as cholesteryl nonanoate and cholesterylcarbonate, or chiral agents with trade names "C-15" and "CB-15" (manufactured by Merck & Co., Ltd.), Or a ferroelectric liquid crystal such as p-decyloxybenzylidene-p-amino-2-methylbutyl cinnamate.
聚合物(A)的合成例Synthesis example of polymer (A)
以下说明聚合物(A)的合成例A-1-1至合成例A-1-3。Synthesis Example A-1-1 to Synthesis Example A-1-3 of the polymer (A) are described below.
合成例A-1-1Synthesis Example A-1-1
在容积500毫升的四颈锥瓶上设置氮气入口、搅拌器、冷凝管及温度计,并导入氮气。然后,在四颈锥瓶中,加入1.51克(0.0025摩尔)由式(2-10)表示的二胺化合物(简称为b-1-1)、9.42克(0.0475摩尔)的4,4’-二胺基二苯基甲烷(4,4’-diaminodiphenylmethane)简称为(b-2-1)、以及80克的N-甲基-2-吡酪烷酮(N-methyl-2-pyrrolidone,简称NMP),并在室温下搅拌至溶解。接着,加入1.25克(0.005摩尔)的由式(1-1)表示的四羧酸二酐化合物(简称为a-1-1)、8.82克(0.045摩尔)的1,2,3,4-环丁烷四羧酸二酐(1,2,3,4-cyclobutane tetracarboxylic dianhydride)(简称为a-2-1)以及20克的NMP,并在室温下反应2小时。待反应结束后,将反应溶液倒入1500毫升水中,以使聚合物析出。然后,过滤所得的聚合物,并重复以甲醇清洗及过滤三次,置入真空烘箱中,以温度60℃进行干燥后,即可得聚合物(A-1-1)。A nitrogen inlet, a stirrer, a condenser, and a thermometer were arranged on a four-necked conical flask with a volume of 500 milliliters, and nitrogen was introduced. Then, in the four-necked conical flask, add 1.51 grams (0.0025 moles) of the diamine compound represented by formula (2-10) (abbreviated as b-1-1), 9.42 grams (0.0475 moles) of 4,4'- Diaminodiphenylmethane (4,4'-diaminodiphenylmethane) is referred to as (b-2-1), and 80 grams of N-methyl-2-pyrrolidone (N-methyl-2-pyrrolidone, referred to as NMP), and stirred at room temperature until dissolved. Then, add 1.25 grams (0.005 moles) of tetracarboxylic dianhydride compounds represented by formula (1-1) (abbreviated as a-1-1), 8.82 grams (0.045 moles) of 1,2,3,4- Cyclobutane tetracarboxylic dianhydride (1,2,3,4-cyclobutane tetracarboxylic dianhydride) (abbreviated as a-2-1) and 20 grams of NMP were reacted at room temperature for 2 hours. After the reaction was finished, the reaction solution was poured into 1500 milliliters of water, so that the polymer was precipitated. Then, the obtained polymer was filtered, washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60° C. to obtain the polymer (A-1-1).
合成例A-1-2至合成例A-1-3Synthesis Example A-1-2 to Synthesis Example A-1-3
合成例A-1-2至合成例A-1-3是以与合成例A-1-1相同的步骤来分别制备聚合物(A-1-2)至聚合物(A-1-3),并且其不同处在于:改变单体的种类及其使用量(如表1所示)。Synthesis Example A-1-2 to Synthesis Example A-1-3 are the same steps as Synthesis Example A-1-1 to prepare polymer (A-1-2) to polymer (A-1-3) respectively , and its difference lies in: changing the type and usage amount of the monomer (as shown in Table 1).
聚合物的合成例Synthesis Example of Polymer
以下说明聚合物的合成例A-2-1至合成例A-2-10。Synthesis Example A-2-1 to Synthesis Example A-2-10 of the polymer are described below.
合成例A-2-1Synthesis Example A-2-1
在容积500毫升的四颈锥瓶上设置氮气入口、搅拌器、冷凝管及温度计,并导入氮气。然后,在四颈锥瓶中,加入1.51克(0.0025摩尔)由式(2-10)表示的二胺化合物(简称为b-1-1)、9.42克(0.0475摩尔)的4,4’-二胺基二苯基甲烷(4,4’-diaminodiphenylmethane)简称为(b-2-1)、以及80克的N-甲基-2-吡酪烷酮(N-methyl-2-pyrrolidone,简称NMP),并在室温下搅拌至溶解。接着,加入1.25克(0.005摩尔)的由式(1-1)表示的四羧酸二酐化合物(简称为a-1-1)、8.82克(0.045摩尔)的1,2,3,4-环丁烷四羧酸二酐(1,2,3,4-cyclobutane tetracarboxylic dianhydride)(简称为a-2-1)以及20克的NMP。在室温下反应6小时后,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升温至60℃,且持续搅拌2小时,以进行酰亚胺化反应。待反应结束后,将反应溶液倒入1500毫升水中,以使聚合物析出。然后,过滤所得的聚合物,并重复以甲醇清洗及过滤三次,置入真空烘箱中,以温度60℃进行干燥后,即可得聚合物(A-2-1)。A nitrogen inlet, a stirrer, a condenser, and a thermometer were arranged on a four-necked conical flask with a volume of 500 milliliters, and nitrogen was introduced. Then, in the four-necked conical flask, add 1.51 grams (0.0025 moles) of the diamine compound represented by formula (2-10) (abbreviated as b-1-1), 9.42 grams (0.0475 moles) of 4,4'- Diaminodiphenylmethane (4,4'-diaminodiphenylmethane) is referred to as (b-2-1), and 80 grams of N-methyl-2-pyrrolidone (N-methyl-2-pyrrolidone, referred to as NMP), and stirred at room temperature until dissolved. Then, add 1.25 grams (0.005 moles) of tetracarboxylic dianhydride compounds represented by formula (1-1) (abbreviated as a-1-1), 8.82 grams (0.045 moles) of 1,2,3,4- Cyclobutane tetracarboxylic dianhydride (1,2,3,4-cyclobutane tetracarboxylic dianhydride) (referred to as a-2-1) and 20 grams of NMP. After reacting at room temperature for 6 hours, 97 g of NMP, 2.55 g of acetic anhydride, and 19.75 g of pyridine were added, the temperature was raised to 60° C., and stirring was continued for 2 hours to carry out imidization reaction. After the reaction was finished, the reaction solution was poured into 1500 milliliters of water, so that the polymer was precipitated. Then, the obtained polymer was filtered, washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60° C. to obtain the polymer (A-2-1).
合成例A-2-2至合成例A-2-10Synthesis Example A-2-2 to Synthesis Example A-2-10
合成例A-2-2至合成例A-2-10是以与合成例A-2-1相同的步骤来分别制备聚合物(A-2-2)至聚合物(A-2-10),并且其不同处在于:改变单体的种类及其使用量(如表1所示)。Synthesis Example A-2-2 to Synthesis Example A-2-10 are the same steps as Synthesis Example A-2-1 to prepare polymer (A-2-2) to polymer (A-2-10) respectively , and its difference lies in: changing the type and usage amount of the monomer (as shown in Table 1).
聚合物的比较合成例A-3-1至比较合成例A-3-3Comparative Synthesis Example A-3-1 to Comparative Synthesis Example A-3-3 of Polymers
比较合成例A-3-1至比较合成例A-3-3是以与合成例A-1-1相同的步骤来分别制备聚合物(A-3-1)至聚合物(A-3-3),并且其不同处在于:改变单体的种类及其使用量(如表2所示)。Comparing Synthesis Example A-3-1 to Comparison Synthesis Example A-3-3 is to prepare respectively polymer (A-3-1) to polymer (A-3- 3), and its difference is: change the kind of monomer and its usage amount (as shown in Table 2).
聚合物的比较合成例A-3-4至比较合成例A-3-6Comparative Synthesis Example A-3-4 to Comparative Synthesis Example A-3-6 of Polymers
比较合成例A-3-4至比较合成例A-3-6是以与合成例A-2-1相同的步骤来分别制备聚合物(A-3-4)至聚合物(A-3-6),并且其不同处在于:改变单体、触媒及脱水剂的种类及其使用量(如表2所示)。Comparative synthesis example A-3-4 to comparison synthesis example A-3-6 is to prepare polymer (A-3-4) to polymer (A-3- 6), and its difference lies in: change the type and usage amount of monomer, catalyst and dehydrating agent (as shown in Table 2).
表1以及表2中简称所对应的化合物如下所示。The compounds corresponding to the abbreviations in Table 1 and Table 2 are as follows.
简称 成分Abbreviation Ingredients
双环[3.3.0]辛烷-2,4,6,8-四羧酸二酐Bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride
双环[4.3.0]壬烷-2,4,7,9-四羧酸二酐Bicyclo[4.3.0]nonane-2,4,7,9-tetracarboxylic dianhydride
三环[6.3.0.02,6]十一烷-35911-四羧酸二酐Tricyclo[6.3.0.0 2,6 ]undecane-35911-tetracarboxylic dianhydride
a-2-1a-2-1
1,2,3,4-环丁烷四羧酸二酐(1,2,3,4-cyclobutane tetracarboxylicdianhydride)1,2,3,4-cyclobutane tetracarboxylic dianhydride (1,2,3,4-cyclobutane tetracarboxylic dianhydride)
a-2-2苯均四羧酸二酐(pyromellitic dianhydride)a-2-2Pyromellitic dianhydride
b-2-1 4,4’-二胺基二苯基甲烷(4,4’-diaminodiphenylmethane)b-2-1 4,4'-Diaminodiphenylmethane (4,4'-diaminodiphenylmethane)
b-2-2 4,4’-二胺基二苯基醚(4,4’-diaminodiphenyl ether)b-2-2 4,4'-diaminodiphenyl ether (4,4'-diaminodiphenyl ether)
b-2-3 对-二胺苯(p-diaminobenzene)b-2-3 p-diaminobenzene (p-diaminobenzene)
b-2-4 1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)b-2-4 1-octadecoxy-2,4-diaminobenzene (1-octadecoxy-2,4-diaminobenzene)
表2Table 2
液晶配向剂、液晶配向膜以及液晶显示组件的实施例与比较例Examples and Comparative Examples of Liquid Crystal Alignment Agents, Liquid Crystal Alignment Films, and Liquid Crystal Display Modules
以下说明液晶配向剂、液晶配向膜以及液晶显示组件的实施例1至实施例13以及比较例1至比较例6:Examples 1 to 13 and Comparative Examples 1 to 6 of liquid crystal alignment agents, liquid crystal alignment films, and liquid crystal display components are described below:
a.液晶配向剂a. Liquid crystal alignment agent
秤取100重量份的聚合物(A-1-1)、1200重量份的N-甲基-2-吡咯烷酮(简称为B-1)以及600重量份的乙二醇正丁基醚(简称为B-2),并且在室温下搅拌混合而形成实施例1的液晶配向剂。Weigh the polymer (A-1-1) of 100 weight parts, the N-methyl-2-pyrrolidone (abbreviated as B-1) of 1200 weight parts and the ethylene glycol n-butyl ether (abbreviated as B-1) of 600 weight parts -2), and stirring and mixing at room temperature to form the liquid crystal alignment agent of Example 1.
b.液晶配向膜及液晶显示组件b. Liquid crystal alignment film and liquid crystal display components
将上述液晶配向剂以印刷机(由日本写真印刷株式会社制造,型号为S15-036)分别涂布在两片具有由ITO(indium-tin-oxide)构成的导电膜的玻璃基板,以形成预涂层。之后,将玻璃基板放置于加热板上,并以温度为100℃、时间为5分钟的条件进行预烘烤。接着,在循环烘箱中,以温度为220℃、时间为30分钟的条件进行后烘烤。最后,经过配向处理后,即可获得上面形成了实施例1的液晶配向膜的玻璃基板。The above-mentioned liquid crystal alignment agent was coated on two glass substrates with a conductive film made of ITO (indium-tin-oxide) with a printing machine (manufactured by Nippon Photo Printing Co., Ltd., model number S15-036) to form a preliminary coating. Afterwards, the glass substrate was placed on a heating plate, and prebaked at a temperature of 100° C. for 5 minutes. Next, post-baking was performed in a circulating oven at a temperature of 220° C. for 30 minutes. Finally, after the alignment treatment, the glass substrate on which the liquid crystal alignment film of Embodiment 1 is formed can be obtained.
将上述所获得的两片上面形成了液晶配向膜的玻璃基板,其中一片涂以热压胶,另一片洒上4μm的隔离壁(spacer)。接着,将两片玻璃基板进行贴合,再以热压机施以10kg的压力,在温度为150℃的条件下进行热压贴合。然后,以液晶注入机(岛津制作所制造,型号为ALIS-100X-CH)进行液晶注入。接着,利用紫外光硬化胶封住液晶注入口,以紫外光灯照光使紫外光硬化胶硬化,并在烘箱中以温度为60℃、时间为30分钟的条件进行液晶回火处理(annealing treatment),即可获得实施例1的液晶显示组件。Of the two glass substrates obtained above on which the liquid crystal alignment film was formed, one of them was coated with hot pressing adhesive, and the other was sprinkled with a 4 μm spacer. Next, the two glass substrates were bonded together, and a pressure of 10 kg was applied by a hot press, and thermal compression bonding was carried out at a temperature of 150° C. Then, liquid crystal injection was performed with a liquid crystal injection machine (manufactured by Shimadzu Corporation, model number ALIS-100X-CH). Next, seal the liquid crystal injection port with UV-curable glue, light the UV-curable glue with UV light, and perform liquid crystal annealing treatment (annealing treatment) in an oven at a temperature of 60°C and a time of 30 minutes. , the liquid crystal display module of Example 1 can be obtained.
将实施例1的液晶显示组件以后述各评价方式进行评价,其结果如表3所示。The liquid crystal display module of Example 1 was evaluated by various evaluation methods described below, and the results are shown in Table 3.
实施例2至实施例13Example 2 to Example 13
实施例2至实施例13的液晶配向剂、液晶配向膜及液晶显示组件是以与实施例1相同的步骤分别制备,并且其不同处在于:改变成分的种类及其使用量,如表3所示。将实施例2至13所制得液晶显示组件以后述评价方式进行评价,其结果如表3所示。The liquid crystal alignment agents, liquid crystal alignment films, and liquid crystal display components of Examples 2 to 13 were prepared in the same steps as in Example 1, and the difference is that the types and amounts of ingredients were changed, as shown in Table 3. Show. The liquid crystal display components prepared in Examples 2 to 13 were evaluated in the following evaluation manner, and the results are shown in Table 3.
比较例1至比较例6Comparative Example 1 to Comparative Example 6
比较例1至比较例6的液晶配向剂、液晶配向膜及液晶显示组件是以与实施例1相同的步骤分别制备,不同的地方在于:改变成分的种类及其使用量,如表4所示。对比较例1至比较例6所制得液晶显示组件以后述评价方式进行评价,其结果如表4所示。The liquid crystal alignment agents, liquid crystal alignment films, and liquid crystal display components of Comparative Example 1 to Comparative Example 6 were prepared in the same steps as in Example 1, except that the types and amounts of ingredients were changed, as shown in Table 4 . The liquid crystal display modules prepared in Comparative Example 1 to Comparative Example 6 were evaluated in the following evaluation manner, and the results are shown in Table 4.
表3及表4中简称所对应的化合物如下所示。The compounds corresponding to the abbreviations in Table 3 and Table 4 are as follows.
评价方式Evaluation method
a.酰亚胺化率a. Imidization rate
酰亚胺化率是指通过聚合物中的酰胺酸官能基数目和酰亚胺环数目的合计量为基准,计算酰亚胺环数目所占的比例,以百分率表示。The imidization rate refers to the ratio of the number of imide rings calculated based on the total amount of the number of amic acid functional groups and the number of imide rings in the polymer, expressed as a percentage.
检测的方法是将合成例的聚合物分别进行减压干燥后,溶解在适当的氘化溶剂(deuteration solvent),例如:氘化二甲基亚砜中,以四甲基硅烷作为基准物质,从室温(例如25℃)下测定1H-核磁共振(1H-Nuclear magnetic resonance,简称1H-NMR)的结果,再由数学式(1)即可求得酰亚胺化率(%)。The detection method is to dry the polymers of the synthesis examples under reduced pressure, and dissolve them in a suitable deuteration solvent, such as deuterated dimethyl sulfoxide, using tetramethylsilane as a reference substance, from The imidization ratio (%) can be calculated from the result of measuring 1 H-NMR ( 1 H-Nuclear magnetic resonance, 1 H-NMR) at room temperature (for example, 25° C.) from mathematical formula (1).
Δ1:NH基质子在10ppm附近的化学位移(chemical shift)所产生的峰值(peak)面积;Δ1: The peak area generated by the chemical shift of NH protons near 10ppm;
Δ2:其它质子的峰值面积;Δ2: peak area of other protons;
α:聚合物的前驱物(聚酰胺酸)中的NH基的1个质子相对于其它质子的个数比例。α: the number ratio of one proton of NH group to other protons in the precursor of the polymer (polyamic acid).
b.紫外线可靠性b. UV reliability
液晶配向膜的紫外线可靠性是以液晶显示组件的电压保持率来评价。进一步而言,液晶显示组件的电压保持率的量测方法如下所述。The UV reliability of liquid crystal alignment film is evaluated by the voltage retention rate of liquid crystal display components. Further, the measurement method of the voltage holding ratio of the liquid crystal display component is as follows.
利用电气测量机台(东阳公司制,型号Model 6254)分别测量实施例1至实施例13及比较例1至比较例6的液晶显示组件的电压保持率。测试条件是施加4伏特电压,历时2毫秒后解除电压,并量测解除起1667毫秒后的电压保持率(计为VHR1)。接着,将液晶显示组件以4200mJ/cm2的紫外光(紫外光照射机型号为KN-SH48K1;光能兴业制造)照射后,以相同测试条件测量经紫外光照射后的电压保持率(计为VHR2)。最后,以数学式(2)计算即可获得电压保持率变化百分比(计为VHRUV(%))。电压保持率变化百分比越低,代表紫外线可靠性越佳。The voltage holding ratios of the liquid crystal display components of Example 1 to Example 13 and Comparative Example 1 to Comparative Example 6 were respectively measured using an electrical measuring machine (manufactured by Toyo Corporation, Model 6254). The test condition is to apply a voltage of 4 volts, release the voltage after 2 milliseconds, and measure the voltage retention rate (referred to as VHR1) after 1667 milliseconds from the release. Next, after irradiating the liquid crystal display assembly with 4200mJ/cm 2 of ultraviolet light (the model of the ultraviolet light irradiation machine is KN-SH48K1; manufactured by Guangneng Xingye), measure the voltage retention rate (meter) after the ultraviolet light irradiation under the same test conditions for VHR2). Finally, the percentage change of the voltage retention rate (calculated as VHR UV (%)) can be obtained by calculating with the mathematical formula (2). A lower percentage change in voltage retention indicates better UV reliability.
电压保持率变化百分比的评价基准如下所示。The evaluation criteria for the percentage change in the voltage retention rate are as follows.
◎:VHRUV<5%◎: VHR UV <5%
○:5%≤VHRUV<10%○: 5%≤VHR UV <10%
△:10%≤VHRUV<20%△: 10%≤VHR UV <20%
╳:20%≤VHRUV ╳: 20%≤VHR UV
表3table 3
表3(续)Table 3 (continued)
表4Table 4
<评价结果><Evaluation result>
由表3以及表4得知,在聚合物(A)中同时使用四羧酸二酐化合物(a-1)以及二胺化合物(b-1)所形成的液晶配向膜(实施例1至实施例13)相比,使用不含有四羧酸二酐化合物(a-1)的聚合物(A)所形成的液晶配向膜(比较例1、3、4及6)的紫外线可靠性不佳;并且使用不含有二胺化合物(b-1)的聚合物(A)所形成的液晶配向膜(比较例2、3、5及6)的紫外线可靠性不佳。It can be known from Table 3 and Table 4 that the liquid crystal alignment film formed by simultaneously using tetracarboxylic dianhydride compound (a-1) and diamine compound (b-1) in polymer (A) (Example 1 to Example 13) compared to the UV reliability of the liquid crystal alignment film (Comparative Examples 1, 3, 4 and 6) formed by using the polymer (A) that does not contain the tetracarboxylic dianhydride compound (a-1); Moreover, the UV reliability of the liquid crystal alignment films (Comparative Examples 2, 3, 5 and 6) formed by using the polymer (A) not containing the diamine compound (b-1) is not good.
此外,当液晶配向剂中聚合物(A)的酰亚胺化率为30%至90%时,所形成的液晶配向膜(实施例7~12)的紫外线可靠性较佳。In addition, when the imidization rate of the polymer (A) in the liquid crystal alignment agent is 30% to 90%, the UV reliability of the formed liquid crystal alignment film (Examples 7-12) is better.
又,当液晶配向剂中聚合物(A)含有式(II-1)、式(II-2)、式(II-26)至式(II-30)所表示的二胺化合物(b-2)时,所形成的液晶配向膜(实施例3、6、9及12)的紫外线可靠性特别佳。Also, when the polymer (A) in the liquid crystal alignment agent contains diamine compounds (b-2) represented by formula (II-1), formula (II-2), formula (II-26) to formula (II-30) ), the UV reliability of the formed liquid crystal alignment films (Examples 3, 6, 9 and 12) is particularly good.
综上所述,本发明的液晶配向剂中的聚合物由含有特定结构的四羧酸二酐化合物的四羧酸二酐组分与含有特定结构的二胺化合物的二胺组分来形成,故将该液晶配向剂应用于液晶配向膜时,所述液晶配向膜具有较佳的紫外线可靠性,因而适用于液晶显示组件。In summary, the polymer in the liquid crystal alignment agent of the present invention is formed by a tetracarboxylic dianhydride component containing a tetracarboxylic dianhydride compound of a specific structure and a diamine component containing a diamine compound of a specific structure, Therefore, when the liquid crystal alignment agent is applied to a liquid crystal alignment film, the liquid crystal alignment film has better ultraviolet reliability, and thus is suitable for liquid crystal display components.
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than limiting them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present invention. scope.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW104109980A TWI570183B (en) | 2015-03-27 | 2015-03-27 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
TW104109980 | 2015-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106010583A CN106010583A (en) | 2016-10-12 |
CN106010583B true CN106010583B (en) | 2018-06-26 |
Family
ID=57082970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610148390.6A Expired - Fee Related CN106010583B (en) | 2015-03-27 | 2016-03-16 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN106010583B (en) |
TW (1) | TWI570183B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202039637A (en) * | 2019-03-27 | 2020-11-01 | 日商大阪曹達股份有限公司 | Polyamic acid composition, polyimide composition, and polyimide molded body |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006070819A1 (en) * | 2004-12-28 | 2006-07-06 | Nissan Chemical Industries, Ltd. | Liquid-crystal alignment material for vertical alignment, liquid-crystal alignment film, and liquid-crystal display element employing the same |
CN103666487A (en) * | 2012-09-14 | 2014-03-26 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element |
CN104342171A (en) * | 2013-07-23 | 2015-02-11 | 奇美实业股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing liquid crystal alignment film |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014189104A1 (en) * | 2013-05-22 | 2014-11-27 | 日産化学工業株式会社 | Liquid crystal alignment agent, and liquid crystal alignment film and liquid crystal display element using same |
-
2015
- 2015-03-27 TW TW104109980A patent/TWI570183B/en not_active IP Right Cessation
-
2016
- 2016-03-16 CN CN201610148390.6A patent/CN106010583B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006070819A1 (en) * | 2004-12-28 | 2006-07-06 | Nissan Chemical Industries, Ltd. | Liquid-crystal alignment material for vertical alignment, liquid-crystal alignment film, and liquid-crystal display element employing the same |
CN103666487A (en) * | 2012-09-14 | 2014-03-26 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element |
CN104342171A (en) * | 2013-07-23 | 2015-02-11 | 奇美实业股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing liquid crystal alignment film |
Also Published As
Publication number | Publication date |
---|---|
CN106010583A (en) | 2016-10-12 |
TW201634584A (en) | 2016-10-01 |
TWI570183B (en) | 2017-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5527538B2 (en) | Liquid crystal aligning agent, method for producing liquid crystal aligning film, and liquid crystal display element | |
JP5041163B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP4900571B2 (en) | Vertical liquid crystal aligning agent and vertical liquid crystal display element | |
CN104342171B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing liquid crystal alignment film | |
CN102778786B (en) | Liquid crystal alignment film and liquid crystal display device | |
CN104130784B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
JP2009157351A (en) | Liquid crystal aligning agent and liquid crystal display element | |
CN105295958B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
CN105273724B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
TWI640573B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN103540325B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
CN105316004A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
CN105087019B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
JP2009265538A (en) | Liquid crystal aligning agent and liquid crystal display element | |
CN105038818A (en) | Liquid crystal alignment agent and application thereof | |
JP2008225010A (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP5045913B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP5224034B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN106010584B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
CN106010583B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly | |
JP2009145530A (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP2009104059A (en) | Liquid crystal aligning agent and transverse electric field type liquid crystal display element | |
TWI550025B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN107779207B (en) | Liquid crystal alignment agent and its application | |
TWI402295B (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180626 Termination date: 20200316 |